Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellowship, Cardology, Georgetown University, School of Medicine 1983 - 1985
  • Resident, Internal Medicine, The George Washington University, School of Medicine and Health Sciences 1980 - 1983
  • M.D., The George Washington University 1980
• 

  Duke Appointment History

  • Associate Professor of Medicine with Tenure, Medicine, Cardiology, Medicine 1997 - 2005
  • Assistant Professor of Medicine, Medicine, Cardiology, Medicine 1988 - 1997
• Recognition
• 

  In the News

  • JUL 6, 2016

    Reuters

    Dr. Mitchell Krucoff comments: Abbott wins U.S. approval for stent that absorbs into body
• Expertise
• 

  Global Scholarship

  • Expertise

    • China (Country) 
    • Israel (Country) 
    • Japan (Country) 
    • Maryland (State or Province) 

  • Research

    • Brazil (Country) 
    • California (State or Province) 
    • China (Country) 
    • Colorado (State or Province) 
    • France (Country) 
    • Japan (Country) 
    • Maryland (State or Province) 
    • Netherlands (Country) 
    • New York (State or Province) 
    • North Carolina (State or Province) 
    • Ohio (State or Province) 
    • Texas (State or Province) 
    • Vermont (State or Province) 

  • Teaching

    • Brazil (Country) 
    • California (State or Province) 
    • China (Country) 
    • Colorado (State or Province) 
    • Florida (State or Province) 
    • France (Country) 
    • Japan (Country) 
    • Maryland (State or Province) 
    • Netherlands (Country) 
    • New York (State or Province) 
    • North Carolina (State or Province) 
    • Ohio (State or Province) 
    • Texas (State or Province) 
    • Vermont (State or Province) 
• Research
• 

  Selected Grants

  • Benefit Risk Tradeoffs Associated with PRO for PAD - Option Period awarded by Food and Drug Administration 2022 - 2024
  • Benefit Risk Tradeoffs Associated with PRO for PAD awarded by Food and Drug Administration 2020 - 2022
  • Core variable Assessment Towards a NatIonal evaluation Program (CATNIP) - Subcontract with Weill Cornell awarded by Weill Cornell Medicine 2020 - 2021
  • CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study awarded by Food and Drug Administration 2019 - 2021
  • Biosensors Registry for BioFreedom Drug Coated Stent (DCS) - LOI awarded by Biosensors Research USA, Inc. 2016 - 2021
  • MDEpiNet J&J Dues awarded by Johnson & Johnson 2020
  • MDEpinNet: RAPID Phase II awarded by W. L. Gore & Associates, Inc. 2019
  • MEDpiNET: Industry Funding awarded by Johnson & Johnson 2017
  • Advancing Medical Device Postmarket Surveillance Infrastructure and Epidemiologic Methodologies through Multi-stakeholder Partnership (U01) awarded by Food and Drug Administration 2013 - 2017
  • Retrospective QTc Analysis for PER977-01-001 awarded by Perosphere, Inc. 2014 - 2015
  • Hostility & Coronary Risk: Role Of Weak Vagal Function awarded by National Institutes of Health 1991 - 1995
• 

  External Relationships

  • 4c Medical
  • Abbott Vascular
  • Angelmed, Inc.
  • Biosensors
  • Cardiovascular Systems, Inc.
  • Celonova
  • Corindus, Inc.
  • Javelin Medical
  • Mitre Medical Corporation
  • Neovasc Incorporated
  • OrbusNeich
  • Provisio
  • Zoll Medical
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Angiolillo, Dominick J., Davide Cao, Usman Baber, Samantha Sartori, Zhongjie Zhang, George Dangas, Shamir Mehta, et al. “Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.” Jacc Cardiovasc Interv 14, no. 13 (July 12, 2021): 1434–46. https://doi.org/10.1016/j.jcin.2021.04.043.
       Full Text  Link to Item
    • Vogel, Rosanne F., Ronak Delewi, Dominick J. Angiolillo, Jeroen M. Wilschut, Miguel E. Lemmert, Roberto Diletti, Ria van Vliet, et al. “Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction.” Jacc Cardiovasc Interv 14, no. 12 (June 28, 2021): 1323–33. https://doi.org/10.1016/j.jcin.2021.04.022.
       Full Text  Link to Item
    • Marquis-Gravel, Guillaume, Philip Urban, Samuel Copt, Davide Capodanno, Stuart J. Pocock, Sara Sadozai Slama, Hans-Peter Stoll, et al. “Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients.” Eurointervention 17, no. 3 (June 25, 2021): 240–47. https://doi.org/10.4244/EIJ-D-20-00749.
       Full Text  Link to Item
    • Vogel, Birgit, Usman Baber, David J. Cohen, Samantha Sartori, Samin K. Sharma, Dominick J. Angiolillo, Serdar Farhan, et al. “Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.” Jama Cardiol, May 15, 2021. https://doi.org/10.1001/jamacardio.2021.1720.
       Full Text  Link to Item
    • Bertges, Daniel J., Roseann White, Yu-Ching Cheng, Tianyi Sun, Niveditta Ramkumar, Philip P. Goodney, Rebecca W. Wilgus, et al. “Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.” J Vasc Surg 73, no. 5 (May 2021): 1702-1714.e11. https://doi.org/10.1016/j.jvs.2020.09.030.
       Full Text  Link to Item
    • Urban, Philip, John Gregson, Ruth Owen, Roxana Mehran, Stephan Windecker, Marco Valgimigli, Olivier Varenne, et al. “Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation: The ARC-High Bleeding Risk Trade-off Model.” Jama Cardiol 6, no. 4 (April 1, 2021): 410–19. https://doi.org/10.1001/jamacardio.2020.6814.
       Full Text  Link to Item
    • Kuno, Toshiki, Bimmer Claessen, Davide Cao, Rishi Chandiramani, Paul Guedeney, Sabato Sorrentino, Mitchell Krucoff, et al. “Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies.” J Thromb Thrombolysis, March 11, 2021. https://doi.org/10.1007/s11239-020-02321-2.
       Full Text  Link to Item
    • Valgimigli, Marco, Roxana Mehran, Anna Franzone, Bruno R. da Costa, Usman Baber, Raffaele Piccolo, Eùgene P. McFadden, et al. “Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.” Jacc Cardiovasc Interv 14, no. 4 (February 22, 2021): 444–56. https://doi.org/10.1016/j.jcin.2020.11.046.
       Full Text  Link to Item
    • Gutierrez, Jorge Antonio, Sunil V. Rao, William Schuyler Jones, Eric A. Secemsky, Aaron W. Aday, Lin Gu, Ryan D. Schulteis, et al. “Survival and Causes of Death Among Veterans With Lower Extremity Revascularization With Paclitaxel-Coated Devices: Insights From the Veterans Health Administration.” J Am Heart Assoc 10, no. 4 (February 16, 2021): e018149. https://doi.org/10.1161/JAHA.120.018149.
       Full Text  Link to Item
    • Ybarra, Luiz F., Stéphane Rinfret, Emmanouil S. Brilakis, Dimitri Karmpaliotis, Lorenzo Azzalini, J Aaron Grantham, David E. Kandzari, et al. “Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.” Circulation 143, no. 5 (February 2, 2021): 479–500. https://doi.org/10.1161/CIRCULATIONAHA.120.046754.
       Full Text  Link to Item
    • Lottes, Aaron E., Eleni M. Whatley, Sara M. Royce, Daniel J. Bertges, Carla A. Erickson, Andrew Farb, Megan L. Fox, et al. “Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional Devices (RAPID) Paclitaxel Pathways Program.” Am Heart J 232 (February 2021): 71–83. https://doi.org/10.1016/j.ahj.2020.10.070.
       Full Text  Link to Item
    • Vlachojannis, Georgios J., Jeroen M. Wilschut, Rosanne F. Vogel, Miguel E. Lemmert, Ronak Delewi, Roberto Diletti, Nancy W. P. L. van der Waarden, et al. “Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.” Circulation 142, no. 24 (December 15, 2020): 2316–28. https://doi.org/10.1161/CIRCULATIONAHA.120.051532.
       Full Text  Link to Item
    • Abraham, William T., Mitchell A. Psotka, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld, Roxana Mehran, Amrut V. Ambardekar, et al. “Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.” Eur J Heart Fail 22, no. 12 (December 2020): 2175–86. https://doi.org/10.1002/ejhf.2018.
       Full Text  Link to Item
    • Abraham, William T., Mitchell A. Psotka, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld, Roxana Mehran, Amrut V. Ambardekar, et al. “Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium.” Jacc Heart Fail 8, no. 12 (December 2020): 961–72. https://doi.org/10.1016/j.jchf.2020.10.002.
       Full Text  Link to Item
    • Samsky, Marc D., Mitchell W. Krucoff, David A. Morrow, William T. Abraham, Fernando Aguel, Andrew D. Althouse, Eric Chen, et al. “Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.” Am Heart J 230 (December 2020): 93–97. https://doi.org/10.1016/j.ahj.2020.09.015.
       Full Text  Link to Item
    • Harrison, Nicholas R., Philip T. Sager, Mitchell W. Krucoff, Michael A. Weber, and William B. White. “Methodological and Regulatory Considerations for Updated Guidance on the Pressor Effects of Drugs.” Ther Innov Regul Sci 54, no. 6 (November 2020): 1473–76. https://doi.org/10.1007/s43441-020-00174-8.
       Full Text  Link to Item
    • Goel, Ridhima, Davide Cao, Rishi Chandiramani, Anastasios Roumeliotis, Moritz Blum, Deepak L. Bhatt, Dominick J. Angiolillo, et al. “Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.” Catheter Cardiovasc Interv, October 10, 2020. https://doi.org/10.1002/ccd.29314.
       Full Text  Link to Item
    • Baber, Usman, George Dangas, Dominick Joseph Angiolillo, David Joel Cohen, Samin Kumar Sharma, Johny Nicolas, Carlo Briguori, et al. “Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.” Eur Heart J 41, no. 37 (October 1, 2020): 3533–45. https://doi.org/10.1093/eurheartj/ehaa670.
       Full Text  Link to Item
    • Capodanno, Davide, Marie-Claude Morice, Dominick J. Angiolillo, Deepak L. Bhatt, Robert A. Byrne, Roisin Colleran, Thomas Cuisset, et al. “Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.” J Am Coll Cardiol 76, no. 12 (September 22, 2020): 1468–83. https://doi.org/10.1016/j.jacc.2020.06.085.
       Full Text  Link to Item
    • Tcheng, James E., Michael Gibson, Mitchell W. Krucoff, Manesh R. Patel, Mullasari Ajit, Jagdish Hiremath, Chandrashekhar Ponde, et al. “SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention.” J Cardiovasc Pharmacol 76, no. 2 (August 2020): 189–96. https://doi.org/10.1097/FJC.0000000000000830.
       Full Text  Link to Item
    • Cao, Davide, Roxana Mehran, George Dangas, Usman Baber, Samantha Sartori, Rishi Chandiramani, Giulio G. Stefanini, et al. “Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients.” J Am Coll Cardiol 75, no. 21 (June 2, 2020): 2711–22. https://doi.org/10.1016/j.jacc.2020.03.070.
       Full Text  Link to Item
    • Seltzer, Jonathan H., Ann Farrell, Neil Goldenberg, Christoph Hornik, Daniel Keene, Mitchell W. Krucoff, Concetta Lipardi, et al. “Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank.” Am Heart J 224 (June 2020): 138–47. https://doi.org/10.1016/j.ahj.2020.02.012.
       Full Text  Link to Item
    • Vlachojannis, Georgios J., Rosanne F. Vogel, Jeroen M. Wilschut, Miguel E. Lemmert, Ronak Delewi, Roberto Diletti, Ria van Vliet, et al. “COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial.” Am Heart J 224 (June 2020): 10–16. https://doi.org/10.1016/j.ahj.2020.03.005.
       Full Text  Link to Item
    • Daubert, Melissa A., Jennifer A. White, Hussein R. Al-Khalidi, Eric J. Velazquez, Sunil V. Rao, Anna Lisa Crowley, Uwe Zeymer, et al. “Cardiac remodeling after large ST-elevation myocardial infarction in the current therapeutic era.” Am Heart J 223 (May 2020): 87–97. https://doi.org/10.1016/j.ahj.2020.02.017.
       Full Text  Link to Item
    • Chandiramani, Rishi, Davide Cao, Bimmer E. Claessen, Sabato Sorrentino, Paul Guedeney, Moritz Blum, Ridhima Goel, et al. “Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.” J Am Heart Assoc 9, no. 7 (April 7, 2020): e014611. https://doi.org/10.1161/JAHA.119.014611.
       Full Text  Link to Item
    • Krucoff, Mitchell W., Philip Urban, Jean-François Tanguay, Thomas McAndrew, Yiran Zhang, Sunil V. Rao, Marie-Claude Morice, et al. “Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents: The LF II Study.” Circ Cardiovasc Interv 13, no. 4 (April 2020): e008603. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008603.
       Full Text  Link to Item
    • Sorrentino, Sabato, Samantha Sartori, Usman Baber, Bimmer E. Claessen, Gennaro Giustino, Jaya Chandrasekhar, Rishi Chandiramani, et al. “Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.” Circ Cardiovasc Interv 13, no. 4 (April 2020): e008226. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008226.
       Full Text  Link to Item
    • Sorrentino, Sabato, Bimmer E. Claessen, Rishi Chandiramani, Paul Guedeney, Birgit Vogel, Usman Baber, Vinuta Rau, et al. “Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.” Circulation 141, no. 11 (March 17, 2020): 891–901. https://doi.org/10.1161/CIRCULATIONAHA.119.041619.
       Full Text  Link to Item
    • Chang, Chun Chin, Norihiro Kogame, Yoshinobu Onuma, Robert A. Byrne, Davide Capodanno, Stephan Windecker, Marie-Angèle Morel, et al. “Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.” Eurointervention 15, no. 13 (January 17, 2020): 1190–98. https://doi.org/10.4244/EIJ-D-19-00552.
       Full Text  Link to Item
    • Samsky, Marc, Mitchell Krucoff, Andrew D. Althouse, William T. Abraham, Philip Adamson, Fernando Aguel, Seth Bilazarian, et al. “Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock.” Am Heart J 219 (January 2020): 1–8. https://doi.org/10.1016/j.ahj.2019.10.006.
       Full Text  Link to Item
    • Brennan, J Matthew, Lisa Wruck, Michael J. Pencina, Robert M. Clare, Renato D. Lopes, John H. Alexander, Sean O’Brien, et al. “Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials.” Am Heart J 218 (December 2019): 110–22. https://doi.org/10.1016/j.ahj.2019.09.002.
       Full Text  Link to Item
    • DeVore, Adam D., Eric Yow, Mitchell W. Krucoff, Matthew W. Sherwood, Linda K. Shaw, Karen Chiswell, Christopher M. O’Connor, Erik Magnus Ohman, and Eric J. Velazquez. “Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction.” Esc Heart Fail 6, no. 6 (December 2019): 1233–42. https://doi.org/10.1002/ehf2.12510.
       Full Text  Open Access Copy  Link to Item
    • Reed, Shelby D., Angelyn O. Fairchild, F Reed Johnson, Juan Marcos Gonzalez, Robert J. Mentz, Mitchell W. Krucoff, and Sreekanth Vemulapalli. “Patients' Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms.” Circ Cardiovasc Interv 12, no. 12 (December 2019): e008051. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008051.
       Full Text  Link to Item
    • Rymer, Jennifer A., Aditya Mandawat, J Dawn Abbott, Mauricio G. Cohen, Justin E. Davies, Ian C. Gilchrist, Sanjit S. Jolly, et al. “Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial.” Am Heart J 218 (December 2019): 84–91. https://doi.org/10.1016/j.ahj.2019.09.014.
       Full Text  Link to Item
    • Mehran, Roxana, Usman Baber, Samin K. Sharma, David J. Cohen, Dominick J. Angiolillo, Carlo Briguori, Jin Y. Cha, et al. “Ticagrelor with or without Aspirin in High-Risk Patients after PCI.” N Engl J Med 381, no. 21 (November 21, 2019): 2032–42. https://doi.org/10.1056/NEJMoa1908419.
       Full Text  Link to Item
    • Holmes, David R., Mitchell W. Krucoff, Chris Mullin, Ghiath Mikdadi, Dale Presser, David Wohns, Andrew Kaplan, et al. “Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events.” J Am Coll Cardiol 74, no. 16 (October 22, 2019): 2047–55. https://doi.org/10.1016/j.jacc.2019.07.084.
       Full Text  Link to Item
    • Vogel, Birgit, Jaya Chandrasekhar, Usman Baber, Ioannis Mastoris, Samantha Sartori, Melissa Aquino, Mitchell W. Krucoff, et al. “Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.” Thromb Haemost 119, no. 10 (October 2019): 1704–11. https://doi.org/10.1055/s-0039-1693463.
       Full Text  Link to Item
    • Pappas, G., J. Berlin, E. Avila-Tang, J. Carroll, J. Drozda, D. Dumont, T. Gross, et al. “Determining value of Coordinated Registry Networks (CRNs): A case of transcatheter valve therapies.” Bmj Surgery, Interventions, and Health Technologies 1, no. 1 (August 19, 2019). https://doi.org/10.1136/bmjsit-2019-000003.
       Full Text
    • Urban, Philip, Roxana Mehran, Roisin Colleran, Dominick J. Angiolillo, Robert A. Byrne, Davide Capodanno, Thomas Cuisset, et al. “Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.” Eur Heart J 40, no. 31 (August 14, 2019): 2632–53. https://doi.org/10.1093/eurheartj/ehz372.
       Full Text  Link to Item
    • Kern, Morton J., Colin Berry, Bernard deBruyne, William Fearon, Allen Jeremias, Nils Johnson, David Kandzari, et al. “Conversation in cardiology: Is there a need for clinical trials for the nonhyperemic pressure ratios?” Catheter Cardiovasc Interv 94, no. 2 (August 1, 2019): 227–32. https://doi.org/10.1002/ccd.28336.
       Full Text  Link to Item
    • Urban, Philip, Roxana Mehran, Roisin Colleran, Dominick J. Angiolillo, Robert A. Byrne, Davide Capodanno, Thomas Cuisset, et al. “Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.” Circulation 140, no. 3 (July 16, 2019): 240–61. https://doi.org/10.1161/CIRCULATIONAHA.119.040167.
       Full Text  Link to Item
    • Moalem, Kamilia, Usman Baber, Jaya Chandrasekhar, Bimmer E. Claessen, Samantha Sartori, Melissa Aquino, George Dangas, et al. “Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry.” Clin Res Cardiol 108, no. 6 (June 2019): 643–50. https://doi.org/10.1007/s00392-018-1392-2.
       Full Text  Link to Item
    • Joyce, Lauren C., Usman Baber, Bimmer E. Claessen, Samantha Sartori, Jaya Chandrasekhar, David J. Cohen, Timothy D. Henry, et al. “Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.” Jacc Cardiovasc Interv 12, no. 10 (May 27, 2019): 983–92. https://doi.org/10.1016/j.jcin.2019.02.033.
       Full Text  Link to Item
    • Chen, Shaojie, Willem-Jan Acou, Marcio G. Kiuchi, Christian Meyer, Philipp Sommer, Martin Martinek, Alexandra Schratter, et al. “Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events: A Systematic Review and Meta-analysis.” Jama Netw Open 2, no. 5 (May 3, 2019): e194934. https://doi.org/10.1001/jamanetworkopen.2019.4934.
       Full Text  Link to Item
    • Rymer, Jennifer A., Lisa A. Kaltenbach, Ajar Kochar, Connie N. Hess, Ian C. Gilchrist, John C. Messenger, Robert A. Harrington, et al. “Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women.” Circ Cardiovasc Interv 12, no. 5 (May 2019): e007086. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007086.
       Full Text  Link to Item
    • Gibson, C Michael, David Holmes, Ghiath Mikdadi, Dale Presser, David Wohns, Megan K. Yee, Andrew Kaplan, et al. “Implantable Cardiac Alert System for Early Recognition of ST-Segment Elevation Myocardial Infarction.” J Am Coll Cardiol 73, no. 15 (April 23, 2019): 1919–27. https://doi.org/10.1016/j.jacc.2019.01.014.
       Full Text  Link to Item
    • Navarese, Eliano P., Sunil V. Rao, and Mitchell W. Krucoff. “Age, STEMI, and Cardiogenic Shock: Never Too Old for PCI?” J Am Coll Cardiol 73, no. 15 (April 23, 2019): 1901–4. https://doi.org/10.1016/j.jacc.2018.12.088.
       Full Text  Link to Item
    • Faggioni, Michela, Usman Baber, Samantha Sartori, Jaya Chandrasekhar, David J. Cohen, Timothy D. Henry, Bimmer E. Claessen, et al. “Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.” Circ Cardiovasc Interv 12, no. 4 (April 2019): e007133. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007133.
       Full Text  Link to Item
    • Schoos, Mikkel, David Power, Usman Baber, Samantha Sartori, Bimmer Claessen, Anton Camaj, Philippe Steg, et al. “Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.” Am J Cardiol 123, no. 5 (March 1, 2019): 709–16. https://doi.org/10.1016/j.amjcard.2018.11.051.
       Full Text  Link to Item
    • Baber, Usman, Daniel E. Leisman, David J. Cohen, C Michael Gibson, Timothy D. Henry, George Dangas, David Moliterno, et al. “Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.” Circ Cardiovasc Qual Outcomes 12, no. 1 (January 2019): e004945. https://doi.org/10.1161/CIRCOUTCOMES.118.004945.
       Full Text  Link to Item
    • Harrison, Robert W., Vaishnavi Radhakrishnan, John C. Allen, Peter S. Lam, Dominic J. Allocco, Sandeep Brar, Martin Fahy, et al. “The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts.” Am Heart J 206 (December 2018): 61–71. https://doi.org/10.1016/j.ahj.2018.08.017.
       Full Text  Link to Item
    • Sorrentino, Sabato, Gennaro Giustino, Usman Baber, Samantha Sartori, David J. Cohen, Timothy D. Henry, Serdar Farhan, et al. “Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).” Am J Cardiol 122, no. 10 (November 15, 2018): 1638–46. https://doi.org/10.1016/j.amjcard.2018.07.041.
       Full Text  Link to Item
    • Weg, Kirian van der, Wichert J. Kuijt, Sebastiaan C. A. M. Bekkers, Jan G. P. Tijssen, Cynthia L. Green, Martijn W. Smulders, Miguel E. Lemmert, Mitchell W. Krucoff, and Anton P. M. Gorgels. “Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury.” Int J Cardiol 271 (November 15, 2018): 240–46. https://doi.org/10.1016/j.ijcard.2018.05.083.
       Full Text  Link to Item
    • Krucoff, Mitchell W., and W Schuyler Jones. “Performance Goal Criteria for Device Evaluation in Lower Extremity Peripheral Vascular Intervention and the Need for Standardized Data Structure: What Is the Sound of One Hand Clapping?” Jacc Cardiovasc Interv 11, no. 19 (October 8, 2018): 2004–6. https://doi.org/10.1016/j.jcin.2018.06.036.
       Full Text  Link to Item
    • Fanaroff, Alexander C., Valarie Morrow, Mitchell W. Krucoff, Jonathan H. Seltzer, Emerson C. Perin, Doris A. Taylor, Leslie W. Miller, et al. “A Path Forward for Regenerative Medicine.” Circ Res 123, no. 4 (August 3, 2018): 495–505. https://doi.org/10.1161/CIRCRESAHA.118.313261.
       Full Text  Link to Item
    • Aziz, Peter F., Stuart Berger, Peter Kowey, Mitchell Krucoff, Martha Lopez-Anderson, Eric Michelson, Silvana Molossi, et al. “The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium.” Am Heart J 202 (August 2018): 104–8. https://doi.org/10.1016/j.ahj.2018.05.011.
       Full Text  Link to Item
    • Saito, Shigeru, Mitchell W. Krucoff, Shigeru Nakamura, Roxana Mehran, Akiko Maehara, Hussein R. Al-Khalidi, Stephen M. Rowland, et al. “Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.” Eur Heart J 39, no. 26 (July 7, 2018): 2460–68. https://doi.org/10.1093/eurheartj/ehy275.
       Full Text  Link to Item
    • Garcia-Garcia, Hector M., Eugène P. McFadden, Andrew Farb, Roxana Mehran, Gregg W. Stone, John Spertus, Yoshinobu Onuma, et al. “Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.” Eur Heart J 39, no. 23 (June 14, 2018): 2192–2207. https://doi.org/10.1093/eurheartj/ehy223.
       Full Text  Link to Item
    • Garcia-Garcia, Hector M., Eugène P. McFadden, Andrew Farb, Roxana Mehran, Gregg W. Stone, John Spertus, Yoshinobu Onuma, et al. “Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.” Circulation 137, no. 24 (June 12, 2018): 2635–50. https://doi.org/10.1161/CIRCULATIONAHA.117.029289.
       Full Text  Link to Item
    • Brilakis, Emmanouil S., Robert Edson, Deepak L. Bhatt, Steven Goldman, David R. Holmes, Sunil V. Rao, Kendrick Shunk, et al. “Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.” Lancet 391, no. 10134 (May 19, 2018): 1997–2007. https://doi.org/10.1016/S0140-6736(18)30801-8.
       Full Text  Link to Item
    • Lansky, Alexandra J., Steven R. Messé, Adam M. Brickman, Michael Dwyer, H. Bart van der Worp, Ronald M. Lazar, Cody G. Pietras, et al. “Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.” Eur Heart J 39, no. 19 (May 14, 2018): 1687–97. https://doi.org/10.1093/eurheartj/ehx037.
       Full Text  Link to Item
    • Weg, Kirian van der, Wichert J. Kuijt, Sebastiaan Cam Bekkers, Jan Gp Tijssen, Cynthia L. Green, Miguel E. Lemmert, Mitchell W. Krucoff, and Anton Pm Gorgels. “Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging.” Eur Heart J Acute Cardiovasc Care 7, no. 3 (April 2018): 246–56. https://doi.org/10.1177/2048872617690887.
       Full Text  Link to Item
    • Baber, Usman, Shawn X. Li, Rebecca Pinnelas, Stuart J. Pocock, Mitchell W. Krucoff, Cono Ariti, C Michael Gibson, et al. “Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).” Circ Cardiovasc Interv 11, no. 3 (March 2018): e006144. https://doi.org/10.1161/CIRCINTERVENTIONS.117.006144.
       Full Text  Link to Item
    • Jones, W Schuyler, Mitchell W. Krucoff, Pablo Morales, Rebecca W. Wilgus, Anne H. Heath, Mary F. Williams, James E. Tcheng, et al. “Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements.” J Vasc Surg 67, no. 2 (February 2018): 637-644.e30. https://doi.org/10.1016/j.jvs.2017.07.141.
       Full Text  Link to Item
    • Jones, W Schuyler, Mitchell W. Krucoff, Pablo Morales, Rebecca W. Wilgus, Anne H. Heath, Mary F. Williams, James E. Tcheng, et al. “Registry Assessment of Peripheral Interventional Devices (RAPID)　- Registry Assessment of Peripheral Interventional Devices Core Data Elements.” Circ J 82, no. 2 (January 25, 2018): 316–22. https://doi.org/10.1253/circj.CJ-17-1156.
       Full Text  Link to Item
    • Koshy, Linda M., Laura H. Aberle, Mitchell W. Krucoff, Connie N. Hess, Ernest Mazzaferri, Sanjit S. Jolly, Alice Jacobs, et al. “Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention.” J Invasive Cardiol 30, no. 1 (January 2018): 18–22.
       Link to Item
    • Chung, Matthew J., Jonathan D. Hansen, Ryan D. Schulteis, Joel C. Boggan, W Schuyler Jones, Thomas J. Povsic, Susan Roberts, Mitchell W. Krucoff, and Sunil V. Rao. “Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement.” Cardiovasc Revasc Med 18, no. 8 (December 2017): 588–91. https://doi.org/10.1016/j.carrev.2017.05.004.
       Full Text  Open Access Copy  Link to Item
    • Reed, Terrie L., Joseph P. Drozda, Kevin M. Baskin, James Tcheng, Karen Conway, Natalia Wilson, Danica Marinac-Dabic, Theodore Heise, and Mitchell W. Krucoff. “Advancing medical device innovation through collaboration and coordination of structured data capture pilots: Report from the Medical Device Epidemiology Network (MDEpiNet) Specific, Measurable, Achievable, Results-Oriented, Time Bound (SMART) Think Tank.” Healthc (Amst) 5, no. 4 (December 2017): 158–64. https://doi.org/10.1016/j.hjdsi.2016.10.004.
       Full Text  Link to Item
    • Seifert, Harry A., Raleigh E. Malik, Mondira Bhattacharya, Kevin R. Campbell, Sally Okun, Carrie Pierce, Jeffrey Terkowitz, J Rick Turner, Mitchell W. Krucoff, and Gregory E. Powell. “Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tank.” Am Heart J 194 (December 2017): 107–15. https://doi.org/10.1016/j.ahj.2017.08.021.
       Full Text  Link to Item
    • Kuijt, Wichert J., Cindy L. Green, Niels J. W. Verouden, Joost D. E. Haeck, Dan Tzivoni, Karel T. Koch, Gregg W. Stone, et al. “What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.” J Electrocardiol 50, no. 6 (November 2017): 952–59. https://doi.org/10.1016/j.jelectrocard.2017.04.009.
       Full Text  Link to Item
    • Shah, Binita, Usman Baber, Stuart J. Pocock, Mitchell W. Krucoff, Cono Ariti, C Michael Gibson, Philippe Gabriel Steg, et al. “White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry).” Circ Cardiovasc Interv 10, no. 9 (September 2017). https://doi.org/10.1161/CIRCINTERVENTIONS.117.004981.
       Full Text  Link to Item
    • Idriss, Salim F., Stuart Berger, Kimberly G. Harmon, Allen Kindman, Robert Kleiman, Martha Lopez-Anderson, Silvana Molossi, et al. “Prevention of sudden cardiac death in the young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research Consortium.” Am Heart J 190 (August 2017): 123–31. https://doi.org/10.1016/j.ahj.2017.05.003.
       Full Text  Link to Item
    • Vemulapalli, Sreekanth, Steven J. Lippmann, Mitchell Krucoff, Adrian F. Hernandez, Lesley H. Curtis, Elyse Foster, Atif Qasim, et al. “Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients.” Am Heart J 189 (July 2017): 146–57. https://doi.org/10.1016/j.ahj.2017.04.012.
       Full Text  Link to Item
    • Kong, David F., Shigeru Saito, Shigeru Nakamura, Roxana Mehran, Stephen M. Rowland, Allison Handler, Hussein R. Al-Khalidi, and Mitchell W. Krucoff. “Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non-ST-elevation acute coronary syndrome.” Am Heart J 187 (May 2017): 112–21. https://doi.org/10.1016/j.ahj.2017.02.004.
       Full Text  Link to Item
    • Faggioni, Michela, Usman Baber, Samantha Sartori, Gennaro Giustino, David J. Cohen, Timothy D. Henry, Serdar Farhan, et al. “Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.” Jacc Cardiovasc Interv 10, no. 7 (April 10, 2017): 645–54. https://doi.org/10.1016/j.jcin.2016.12.003.
       Full Text  Link to Item
    • Damman, Peter, Robbert J. de Winter, and Mitchell W. Krucoff. “ST-elevation no myocardial infarction.” J Thromb Thrombolysis 43, no. 3 (April 2017): 426–27. https://doi.org/10.1007/s11239-016-1454-0.
       Full Text  Link to Item
    • Lansky, Alexandra J., Steven R. Messé, Adam M. Brickman, Michael Dwyer, H Bart van der Worp, Ronald M. Lazar, Cody G. Pietras, et al. “Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.” J Am Coll Cardiol 69, no. 6 (February 14, 2017): 679–91. https://doi.org/10.1016/j.jacc.2016.11.045.
       Full Text  Link to Item
    • Sanghvi, Kintur, and Mitchell W. Krucoff. “Editorial: Radial to Coronary: Ideal Catheter for the Ideal Approach.” J Interv Cardiol 30, no. 1 (February 2017): 43–45. https://doi.org/10.1111/joic.12364.
       Full Text  Link to Item
    • Baber, Usman, George Dangas, David J. Cohen, C Michael Gibson, Shamir R. Mehta, Dominick J. Angiolillo, Stuart J. Pocock, et al. “Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.” Am Heart J 182 (December 2016): 125–34. https://doi.org/10.1016/j.ahj.2016.09.006.
       Full Text  Link to Item
    • Chen, Shaojie, Ying Dong, Marcio Galindo Kiuchi, Jiazhi Wang, Ruotian Li, Zhiyu Ling, Tingquan Zhou, et al. “Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.” Jama Pediatr 170, no. 12 (December 1, 2016): 1156–63. https://doi.org/10.1001/jamapediatrics.2016.2055.
       Full Text  Link to Item
    • Harrison, Robert W., Vaishnavi Radhakrishnan, Peter S. Lam, Dominic J. Allocco, Sandeep Brar, Martin Fahy, Rebecca Fisher, et al. “Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts.” Am Heart J 182 (December 2016): 103–10. https://doi.org/10.1016/j.ahj.2016.07.011.
       Full Text  Link to Item
    • Jones, W Schuyler, Matthew T. Roe, Elliott M. Antman, Mark J. Pletcher, Robert A. Harrington, Russell L. Rothman, William J. Oetgen, et al. “The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease.” J Am Coll Cardiol 68, no. 17 (October 25, 2016): 1898–1907. https://doi.org/10.1016/j.jacc.2016.07.781.
       Full Text  Link to Item
    • Rao, Sunil V., Uwe Zeymer, Pamela S. Douglas, Hussein Al-Khalidi, Jennifer A. White, Jingyu Liu, Howard Levy, et al. “Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.” J Am Coll Cardiol 68, no. 7 (August 16, 2016): 715–23. https://doi.org/10.1016/j.jacc.2016.05.053.
       Full Text  Link to Item
    • Chen, Shaojie, Zhenglong Wang, Marcio Galindo Kiuchi, Bruno Rustum Andrea, Mitchell W. Krucoff, Shaowen Liu, and Helmut Pürerfellner. “Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.” Clin Res Cardiol 105, no. 8 (August 2016): 687–98. https://doi.org/10.1007/s00392-016-0973-1.
       Full Text  Link to Item
    • Ferrante, Giuseppe, Sunil V. Rao, Peter Jüni, Bruno R. Da Costa, Bernhard Reimers, Gianluigi Condorelli, Angelo Anzuini, et al. “Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials.” Jacc Cardiovasc Interv 9, no. 14 (July 25, 2016): 1419–34. https://doi.org/10.1016/j.jcin.2016.04.014.
       Full Text  Link to Item
    • Yu, Jennifer, Usman Baber, Ioannis Mastoris, George Dangas, Samantha Sartori, Philippe Gabriel Steg, David J. Cohen, et al. “Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents.” Jacc Cardiovasc Interv 9, no. 14 (July 25, 2016): 1461–69. https://doi.org/10.1016/j.jcin.2016.04.004.
       Full Text  Link to Item
    • Mark, Daniel B., Jerome J. Federspiel, Patricia A. Cowper, Kevin J. Anstrom, Udo Hoffmann, Manesh R. Patel, Linda Davidson-Ray, et al. “Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease.” Ann Intern Med 165, no. 2 (July 19, 2016): 94–102. https://doi.org/10.7326/M15-2639.
       Full Text  Link to Item
    • Baber, Usman, George Dangas, Jaya Chandrasekhar, Samantha Sartori, Philippe Gabriel Steg, David J. Cohen, Gennaro Giustino, et al. “Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry.” Jacc Cardiovasc Interv 9, no. 13 (July 11, 2016): 1349–57. https://doi.org/10.1016/j.jcin.2016.04.009.
       Full Text  Link to Item
    • Hermiller, James B., Robert J. Applegate, Colleen Baird, Michael M. Butler, David Rutledge, Jin Wang, Kalyan Kakarala, Mitchell W. Krucoff, and Krishnankutty Sudhir. “Clinical outcomes in real-world patients with bifurcation lesions receiving Xience V everolimus-eluting stents: Four-year results from the Xience V USA study.” Catheter Cardiovasc Interv 88, no. 1 (July 2016): 62–70. https://doi.org/10.1002/ccd.26217.
       Full Text  Link to Item
    • Turner, J Rick, Peter R. Kowey, Ignacio Rodriguez, Christopher H. Cabell, Gary Gintant, Cynthia L. Green, Barbara Lopez Kunz, et al. “The Cardiac Safety Research Consortium enters its second decade: An invitation to participate.” Am Heart J 177 (July 2016): 96–101. https://doi.org/10.1016/j.ahj.2016.04.009.
       Full Text  Link to Item
    • Baber, Usman, Roxana Mehran, Gennaro Giustino, David J. Cohen, Timothy D. Henry, Samantha Sartori, Cono Ariti, et al. “Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.” J Am Coll Cardiol 67, no. 19 (May 17, 2016): 2224–34. https://doi.org/10.1016/j.jacc.2016.02.064.
       Full Text  Link to Item
    • Weg, Kirian van der, Mohamed Majidi, Joost D. E. Haeck, Jan G. P. Tijssen, Cynthia L. Green, Karel T. Koch, Wichert J. Kuijt, Mitchell W. Krucoff, Anton P. M. Gorgels, and Robbert J. de Winter. “Ventricular arrhythmia burst is an independent indicator of larger infarct size even in optimal reperfusion in STEMI.” J Electrocardiol 49, no. 3 (May 2016): 345–52. https://doi.org/10.1016/j.jelectrocard.2016.03.013.
       Full Text  Link to Item
    • Green, Cynthia L., Cavell Brownie, Dennis D. Boos, Jye-Chyi Lu, and Mitchell W. Krucoff. “Maximum likelihood estimation of time to first event in the presence of data gaps and multiple events.” Stat Methods Med Res 25, no. 2 (April 2016): 775–92. https://doi.org/10.1177/0962280212466089.
       Full Text  Link to Item
    • Hermiller, James B., Mitchell W. Krucoff, Dean J. Kereiakes, Stephan Windecker, P Gabriel Steg, Robert W. Yeh, David J. Cohen, et al. “Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.” Jacc Cardiovasc Interv 9, no. 2 (January 25, 2016): 138–47. https://doi.org/10.1016/j.jcin.2015.10.001.
       Full Text  Link to Item
    • Newman, Anne B., M Larissa Avilés-Santa, Garnet Anderson, Gerardo Heiss, Wm James Howard, Mitchell Krucoff, Lewis H. Kuller, et al. “Embedding clinical interventions into observational studies.” Contemp Clin Trials 46 (January 2016): 100–105. https://doi.org/10.1016/j.cct.2015.11.017.
       Full Text  Link to Item
    • Zeitler, Emily P., Sana M. Al-Khatib, Joseph P. Drozda, Larry G. Kessler, Ajay J. Kirtane, David F. Kong, John Laschinger, et al. “Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).” Am Heart J 171, no. 1 (January 2016): 64-72.e1-2. https://doi.org/10.1016/j.ahj.2015.07.029.
       Full Text  Link to Item
    • Rao, Sunil V., Uwe Zeymer, Pamela S. Douglas, Hussein Al-Khalidi, Jingyu Liu, C Michael Gibson, Robert W. Harrison, Diane S. Joseph, Reinilde Heyrman, and Mitchell W. Krucoff. “A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.” Am Heart J 170, no. 5 (November 2015): 929–37. https://doi.org/10.1016/j.ahj.2015.08.017.
       Full Text  Link to Item
    • Velazquez, Eric J., Zainab Samad, Hussein R. Al-Khalidi, Chithra Sangli, Paul A. Grayburn, Joseph M. Massaro, Susanna R. Stevens, Ted E. Feldman, and Mitchell W. Krucoff. “The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison.” Am Heart J 170, no. 5 (November 2015): 1050-1059.e3. https://doi.org/10.1016/j.ahj.2015.08.004.
       Full Text  Link to Item
    • Krucoff, Mitchell W., Art Sedrakyan, and Sharon-Lise T. Normand. “Bridging Unmet Medical Device Ecosystem Needs With Strategically Coordinated Registries Networks.” Jama 314, no. 16 (October 27, 2015): 1691–92. https://doi.org/10.1001/jama.2015.11036.
       Full Text  Link to Item
    • Weg, Kirian van der, Wichert J. Kuijt, Jan G. P. Tijssen, Sebastiaan C. A. M. Bekkers, Joost D. E. Haeck, Cynthia L. Green, Miguel E. Lemmert, Robbert J. de Winter, Anton P. M. Gorgels, and Mitchell W. Krucoff. “Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI.” Int J Cardiol 195 (September 15, 2015): 136–42. https://doi.org/10.1016/j.ijcard.2015.05.106.
       Full Text  Link to Item
    • Hess, Connie N., Mitchell W. Krucoff, Shubin Sheng, Kevin J. Anstrom, W Britt Barham, Ian C. Gilchrist, Robert A. Harrington, et al. “Comparison of quality-of-life measures after radial versus femoral artery access for cardiac catheterization in women: Results of the Study of Access Site for Enhancement of Percutaneous Coronary Intervention for Women quality-of-life substudy.” Am Heart J 170, no. 2 (August 2015): 371–79. https://doi.org/10.1016/j.ahj.2015.04.024.
       Full Text  Link to Item
    • Stone, Gregg W., Alec S. Vahanian, David H. Adams, William T. Abraham, Jeffrey S. Borer, Jeroen J. Bax, Joachim Schofer, et al. “Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: A consensus document from the mitral valve academic research consortium.” Eur Heart J 36, no. 29 (August 1, 2015): 1851–77. https://doi.org/10.1093/eurheartj/ehv281.
       Full Text  Link to Item
    • Stone, Gregg W., Alec S. Vahanian, David H. Adams, William T. Abraham, Jeffrey S. Borer, Jeroen J. Bax, Joachim Schofer, et al. “Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium.” J Am Coll Cardiol 66, no. 3 (July 21, 2015): 278–307. https://doi.org/10.1016/j.jacc.2015.05.046.
       Full Text  Link to Item
    • Hess, Connie N., Matthew T. Roe, Robert M. Clare, Karen Chiswell, Joseph Kelly, James E. Tcheng, Emil Hagstrom, et al. “Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention.” J Am Heart Assoc 4, no. 7 (July 6, 2015). https://doi.org/10.1161/JAHA.115.001779.
       Full Text  Open Access Copy  Link to Item
    • Sabol, Mary Elizabeth, John Finkle, Mitch Krucoff, Norman Stockbridge, Nancy Parkhill, Kaori Shinagawa, Kenneth Mahaffey, et al. “Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report Forms.” Ther Innov Regul Sci 49, no. 4 (July 2015): 511–13. https://doi.org/10.1177/2168479014567319.
       Full Text  Link to Item
    • Cannon, Christopher P., Michael A. Blazing, Robert P. Giugliano, Amy McCagg, Jennifer A. White, Pierre Theroux, Harald Darius, et al. “Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.” N Engl J Med 372, no. 25 (June 18, 2015): 2387–97. https://doi.org/10.1056/NEJMoa1410489.
       Full Text  Link to Item
    • Généreux, Philippe, David R. Rutledge, Tullio Palmerini, Adriano Caixeta, Elvin Kedhi, James B. Hermiller, Jin Wang, et al. “Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials.” Circ Cardiovasc Interv 8, no. 5 (May 2015). https://doi.org/10.1161/CIRCINTERVENTIONS.114.001362.
       Full Text  Link to Item
    • Hess, Connie N., Mitchell W. Krucoff, and Sunil V. Rao. “Reply: Transradial PCI in Women: Zeroing in on Crossovers.” Jacc Cardiovasc Interv 8, no. 4 (April 20, 2015): 639. https://doi.org/10.1016/j.jcin.2015.01.010.
       Full Text  Link to Item
    • Douglas, Pamela S., Udo Hoffmann, Manesh R. Patel, Daniel B. Mark, Hussein R. Al-Khalidi, Brendan Cavanaugh, Jason Cole, et al. “Outcomes of anatomical versus functional testing for coronary artery disease.” N Engl J Med 372, no. 14 (April 2, 2015): 1291–1300. https://doi.org/10.1056/NEJMoa1415516.
       Full Text  Link to Item
    • Patel, Manesh R., Michael S. Conte, Donald E. Cutlip, Nabil Dib, Patrick Geraghty, William Gray, William R. Hiatt, et al. “Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).” J Am Coll Cardiol 65, no. 9 (March 10, 2015): 931–41. https://doi.org/10.1016/j.jacc.2014.12.036.
       Full Text  Link to Item
    • Hess, Connie N., Eric D. Peterson, Megan L. Neely, David Dai, William B. Hillegass, Mitchell W. Krucoff, Michael A. Kutcher, et al. “Response to letter regarding article, "The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry".” Circulation 131, no. 8 (February 24, 2015): e358. https://doi.org/10.1161/CIRCULATIONAHA.114.013278.
       Full Text  Link to Item
    • Majidi, Mohamed, Andrzej S. Kosinski, Sana M. Al-Khatib, Lilian Smolders, Ecaterina Cristea, Alexandra J. Lansky, Gregg W. Stone, et al. “Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream".” Eur Heart J Acute Cardiovasc Care 4, no. 1 (February 2015): 51–59. https://doi.org/10.1177/2048872614532414.
       Full Text  Link to Item
    • Patel, M. R., M. S. Conte, D. E. Cutlip, N. Dib, P. Geraghty, W. Gray, W. R. Hiatt, et al. “Erratum: Evaluation and treatment of patients with lower extremity peripheral artery disease: Consensus definitions from Peripheral Academic Research Consortium (PARC) (Journal of the American College of Cardiology (2015) 65:(931-41)).” Journal of the American College of Cardiology 65, no. 23 (January 1, 2015): 2578–79. https://doi.org/10.1016/j.jacc.2015.04.049.
       Full Text
    • Mauri, Laura, Dean J. Kereiakes, Robert W. Yeh, Priscilla Driscoll-Shempp, Donald E. Cutlip, P Gabriel Steg, Sharon-Lise T. Normand, et al. “Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.” N Engl J Med 371, no. 23 (December 4, 2014): 2155–66. https://doi.org/10.1056/NEJMoa1409312.
       Full Text  Link to Item
    • Gibson, C Michael, Mitchell Krucoff, Ajay J. Kirtane, Sunil V. Rao, Judith A. Mackall, Ray Matthews, Samir Saba, Ron Waksman, and David Holmes. “Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients.” Am Heart J 168, no. 4 (October 2014): 424-429.e1. https://doi.org/10.1016/j.ahj.2014.05.010.
       Full Text  Link to Item
    • Lincoff, A Michael, Matthew Roe, Philip Aylward, John Galla, Andrzej Rynkiewicz, Victor Guetta, Michael Zelizko, et al. “Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.” Eur Heart J 35, no. 37 (October 1, 2014): 2516–23. https://doi.org/10.1093/eurheartj/ehu177.
       Full Text  Link to Item
    • Lee, Michael S., Tae Yang, Ehtisham Mahmud, Kyung Woo Park, Hyo-Soo Kim, Moo Hyun Kim, George Dangas, James Hermiller, Mitchell Krucoff, and David Rutledge. “Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents.” J Invasive Cardiol 26, no. 9 (September 2014): 420–26.
       Link to Item
    • Gibson, Michael C., Mitchell Krucoff, David Fischell, Tim A. Fischell, David Keenan, Cassandra Abueg, Charmaine Patel, and David Holmes. “Rationale and design of the AngeLmed for Early Recognition and Treatment of STEMI trial: a randomized, prospective clinical investigation.” Am Heart J 168, no. 2 (August 2014): 168–74. https://doi.org/10.1016/j.ahj.2014.05.008.
       Full Text  Link to Item
    • Rao, Sunil V., Connie N. Hess, Britt Barham, Laura H. Aberle, Kevin J. Anstrom, Tejan B. Patel, Jesse P. Jorgensen, et al. “A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial.” Jacc Cardiovasc Interv 7, no. 8 (August 2014): 857–67. https://doi.org/10.1016/j.jcin.2014.04.007.
       Full Text  Link to Item
    • Hermiller, James B., David R. Rutledge, Vivian W. Mao, Weiying Zhao, Jin Wang, Luis Gruberg, William Lombardi, Samin K. Sharma, and Mitchell W. Krucoff. “Clinical outcomes in real-world patients with small vessel disease treated with XIENCE V® everolimus-eluting stents: one year results from the XIENCE V® USA condition of approval post-market study.” Catheter Cardiovasc Interv 84, no. 1 (July 1, 2014): 7–16. https://doi.org/10.1002/ccd.25325.
       Full Text  Link to Item
    • Hess, Connie N., Eric D. Peterson, Megan L. Neely, David Dai, William B. Hillegass, Mitchell W. Krucoff, Michael A. Kutcher, et al. “The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry.” Circulation 129, no. 22 (June 3, 2014): 2277–86. https://doi.org/10.1161/CIRCULATIONAHA.113.006356.
       Full Text  Link to Item
    • Douglas, Pamela S., Udo Hoffmann, Kerry L. Lee, Daniel B. Mark, Hussein R. Al-Khalidi, Kevin Anstrom, Rowena J. Dolor, et al. “PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial.” Am Heart J 167, no. 6 (June 2014): 796-803.e1. https://doi.org/10.1016/j.ahj.2014.03.003.
       Full Text  Link to Item
    • Leder, Drew, and Mitchell W. Krucoff. “"Take your pill": the role and fantasy of pills in modern medicine.” J Altern Complement Med 20, no. 6 (June 2014): 421–27. https://doi.org/10.1089/acm.2013.0447.
       Full Text  Link to Item
    • Voigt, Jeff, M. Sasha John, Andrew Taylor, Mitchell Krucoff, Matthew R. Reynolds, and C. Michael Gibson. “A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States.” Clin Cardiol 37, no. 5 (May 2014): 312–21. https://doi.org/10.1002/clc.22260.
       Full Text  Link to Item
    • Kern, Morton J., Robert J. Applegate, Malcolm Bell, Emmanouil S. Brilakis, Samuel M. Butman, Richard G. Bach, Prashant Kaul, et al. “Conversations in cardiology: bridging antiplatelet therapy before surgery.” Catheter Cardiovasc Interv 83, no. 5 (April 1, 2014): 748–52. https://doi.org/10.1002/ccd.25319.
       Full Text  Link to Item
    • Chen, Shaojie, Yuehui Yin, Zhiyu Ling, and Mitchell W. Krucoff. “Short and long term effect of adjunctive intra-aortic balloon pump use for patients undergoing high risk reperfusion therapy: a meta-analysis of 10 international randomised trials.” Heart 100, no. 4 (February 2014): 303–10. https://doi.org/10.1136/heartjnl-2013-304198.
       Full Text  Link to Item
    • Rao, Sunil V., Jennifer A. Tremmel, Ian C. Gilchrist, Pinak B. Shah, Rajiv Gulati, Adhir R. Shroff, Van Crisco, et al. “Best practices for transradial angiography and intervention: a consensus statement from the society for cardiovascular angiography and intervention's transradial working group.” Catheter Cardiovasc Interv 83, no. 2 (February 2014): 228–36. https://doi.org/10.1002/ccd.25209.
       Full Text  Link to Item
    • Mehran, Roxana, Usman Baber, Philippe Gabriel Steg, Cono Ariti, Giora Weisz, Bernhard Witzenbichler, Timothy D. Henry, et al. “Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.” Lancet 382, no. 9906 (November 23, 2013): 1714–22. https://doi.org/10.1016/S0140-6736(13)61720-1.
       Full Text  Link to Item
    • Green, Cynthia L., David J. Whellan, Lindsay Lambe, S. E. Bellibas, Peter Wijngaard, Jayne Prats, and Mitchell W. Krucoff. “Electrocardiographic safety of cangrelor, a new intravenous antiplatelet agent: a randomized, double-blind, placebo- and moxifloxacin-controlled thorough QT study.” J Cardiovasc Pharmacol 62, no. 5 (November 2013): 466–78. https://doi.org/10.1097/FJC.0b013e3182a2630d.
       Full Text  Link to Item
    • Sudhir, Krishnankutty, James B. Hermiller, Srihari S. Naidu, Timothy D. Henry, Vivian W. Mao, Weiying Zhao, Joanne M. Ferguson, et al. “Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V® everolimus-eluting stents: one-year results from the XIENCE V USA study.” Catheter Cardiovasc Interv 82, no. 4 (October 1, 2013): E385–94. https://doi.org/10.1002/ccd.24749.
       Full Text  Link to Item
    • Hess, Connie N., Sunil V. Rao, David F. Kong, Laura H. Aberle, Kevin J. Anstrom, C Michael Gibson, Ian C. Gilchrist, et al. “Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).” Am Heart J 166, no. 3 (September 2013): 421–28. https://doi.org/10.1016/j.ahj.2013.06.013.
       Full Text  Link to Item
    • Chen, Shaojie, Zhiyu Ling, Márcio Galindo Kiuchi, Yuehui Yin, and Mitchell W. Krucoff. “The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.” Europace 15, no. 7 (July 2013): 992–1001. https://doi.org/10.1093/europace/eus419.
       Full Text  Link to Item
    • Kern, Morton, Robert Applegate, Richard G. Bach, Steven R. Bailey, Thomas M. Bashore, Theodore A. Bass, Malcolm Bell, et al. “Conversation in cardiology: should FFR and IVUS be counted as PCI?” Catheter Cardiovasc Interv 82, no. 1 (July 1, 2013): 110–15. https://doi.org/10.1002/ccd.24854.
       Full Text  Link to Item
    • Rao, Sunil V., and Mitchell W. Krucoff. “Radial first: paradox+proficiency=opportunity.” J Am Heart Assoc 2, no. 3 (June 7, 2013): e000281. https://doi.org/10.1161/JAHA.113.000281.
       Full Text  Link to Item
    • Chen, Shaojie, Yuehui Yin, Xianbin Lan, Zengzhang Liu, Zhiyu Ling, Li Su, Márcio Galindo Kiuchi, et al. “Paced QRS duration as a predictor for clinical heart failure events during right ventricular apical pacing in patients with idiopathic complete atrioventricular block: results from an observational cohort study (PREDICT-HF).” Eur J Heart Fail 15, no. 3 (March 2013): 352–59. https://doi.org/10.1093/eurjhf/hfs199.
       Full Text  Link to Item
    • Hess, Connie N., Sunil V. Rao, David F. Kong, Julie M. Miller, Kevin J. Anstrom, Olivier F. Bertrand, Jean-Philippe Collet, et al. “TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.” Am Heart J 165, no. 3 (March 2013): 344-53.e1. https://doi.org/10.1016/j.ahj.2012.09.008.
       Full Text  Link to Item
    • Chen, Shaojie, Ying Dong, Yuehui Yin, and Mitchell W. Krucoff. “Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.” Heart 99, no. 2 (January 2013): 76–82. https://doi.org/10.1136/heartjnl-2012-302126.
       Full Text  Link to Item
    • Kappetein, A Pieter, Stuart J. Head, Philippe Généreux, Nicolo Piazza, Nicolas M. van Mieghem, Eugene H. Blackstone, Thomas G. Brott, et al. “Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.” J Thorac Cardiovasc Surg 145, no. 1 (January 2013): 6–23. https://doi.org/10.1016/j.jtcvs.2012.09.002.
       Full Text  Link to Item
    • Uchida, Takahiro, Fumiaki Ikeno, Koji Ikeda, Yuka Suzuki, Koji Todaka, Hiroyoshi Yokoi, Gary Thompson, Mitchel Krucoff, Shigeru Saito, and Shigeru Harmonization by Doing Program Working Group. “Global cardiovascular device innovation: Japan-USA synergies: Harmonization by Doing (HBD) program, a consortium of regulatory agencies, medical device industry, and academic institutions.” Circ J 77, no. 7 (2013): 1714–18. https://doi.org/10.1253/circj.cj-12-1431.
       Full Text  Link to Item
    • Hermiller, James B., David R. Rutledge, Luis Gruberg, John N. Katopodis, William Lombardi, Vivian W. Mao, Weiying Zhao, et al. “Sustained low clinical event rates in real-world patients receiving everolimus-eluting coronary stent system from a large, prospective, condition of approval study: 2-year clinical outcomes from the XIENCE V USA Study.” J Interv Cardiol 25, no. 6 (December 2012): 565–75. https://doi.org/10.1111/j.1540-8183.2012.00766.x.
       Full Text  Link to Item
    • Kappetein, A Pieter, Stuart J. Head, Philippe Généreux, Nicolo Piazza, Nicolas M. van Mieghem, Eugene H. Blackstone, Thomas G. Brott, et al. “Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.” Eurointervention 8, no. 7 (November 22, 2012): 782–95. https://doi.org/10.4244/EIJV8I7A121.
       Full Text  Link to Item
    • Chen, Shaojie, Yuehui Yin, and Mitchell W. Krucoff. “Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.” Europace 14, no. 11 (November 2012): 1602–7. https://doi.org/10.1093/europace/eus168.
       Full Text  Link to Item
    • Kappetein, Arie Pieter, Stuart J. Head, Philippe Généreux, Nicolo Piazza, Nicolas M. van Mieghem, Eugene H. Blackstone, Thomas G. Brott, et al. “Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2).” Eur J Cardiothorac Surg 42, no. 5 (November 2012): S45–60. https://doi.org/10.1093/ejcts/ezs533.
       Full Text  Link to Item
    • Lefebvre, Cedric W., Mitchell W. Krucoff, Brian C. Hiestand, Abhinav Chandra, Charles B. Cairns, Joseph Massaro, and James Hoekstra. “Comparison of an automated algorithm to expert physician interpretation of 80-lead body surface mapping in the evaluation of acute myocardial ischemia and infarction in patients presenting to the emergency department with chest pain: results from the Optimal Cardiovascular Diagnostic Evaluation Enabling Faster Treatment of Myocardial Infarction trial.” J Electrocardiol 45, no. 6 (November 2012): 702–7. https://doi.org/10.1016/j.jelectrocard.2012.07.002.
       Full Text  Link to Item
    • Kappetein, A Pieter, Stuart J. Head, Philippe Généreux, Nicolo Piazza, Nicolas M. van Mieghem, Eugene H. Blackstone, Thomas G. Brott, et al. “Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.” J Am Coll Cardiol 60, no. 15 (October 9, 2012): 1438–54. https://doi.org/10.1016/j.jacc.2012.09.001.
       Full Text  Link to Item
    • Bates, Katherine E., Victoria L. Vetter, Jennifer S. Li, Susan Cummins, Fernando Aguel, Christopher Almond, Anne M. Dubin, et al. “Pediatric cardiovascular safety: challenges in drug and device development and clinical application.” Am Heart J 164, no. 4 (October 2012): 481–92. https://doi.org/10.1016/j.ahj.2012.07.019.
       Full Text  Link to Item
    • Chen, Shaojie, Yuehui Yin, and Mitchell W. Krucoff. “Should rhythm control be preferred in younger atrial fibrillation patients?” J Interv Card Electrophysiol 35, no. 1 (October 2012): 71–80. https://doi.org/10.1007/s10840-012-9687-0.
       Full Text  Link to Item
    • Kappetein, A Pieter, Stuart J. Head, Philippe Généreux, Nicolo Piazza, Nicolas M. van Mieghem, Eugene H. Blackstone, Thomas G. Brott, et al. “Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.” Eur Heart J 33, no. 19 (October 2012): 2403–18. https://doi.org/10.1093/eurheartj/ehs255.
       Full Text  Link to Item
    • Chen, Shaojie, Zhiyu Ling, Yuehui Yin, Chengzhi Li, Bo Zhang, Bernhard Zrenner, and Mitchell W. Krucoff. “The comparison of epicardial focused ultrasound circumferential pulmonary vein ablation and BOX ablation--results from experimental acute atrial fibrillation.” J Interv Card Electrophysiol 34, no. 2 (August 2012): 153–59. https://doi.org/10.1007/s10840-011-9659-9.
       Full Text  Link to Item
    • Crawford, Geoffrey B., Ralph G. Brindis, Mitchell W. Krucoff, Benjamin P. Mansalis, and John D. Carroll. “Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.” Catheter Cardiovasc Interv 80, no. 2 (August 1, 2012): 157–67. https://doi.org/10.1002/ccd.24347.
       Full Text  Link to Item
    • Krucoff, Mitchell W., Ralph G. Brindis, Patricia K. Hodgson, Michael J. Mack, and David R. Holmes. “Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective.” Jacc Cardiovasc Interv 5, no. 7 (July 2012): 790–96. https://doi.org/10.1016/j.jcin.2012.03.023.
       Full Text  Link to Item
    • Naidu, Srihari S., Mitchell W. Krucoff, David R. Rutledge, Vivian W. Mao, Weiying Zhao, Qing Zheng, Olivia Wilburn, Krishnankutty Sudhir, Charles Simonton, and James B. Hermiller. “Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study.” Jacc Cardiovasc Interv 5, no. 6 (June 2012): 626–35. https://doi.org/10.1016/j.jcin.2012.02.014.
       Full Text  Link to Item
    • Damman, Peter, Wichert J. Kuijt, Pier Woudstra, Joost D. E. Haeck, Karel T. Koch, Youlan L. Gu, Jan P. van Straalen, et al. “Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.” Am Heart J 163, no. 5 (May 2012): 783–89. https://doi.org/10.1016/j.ahj.2012.01.004.
       Full Text  Link to Item
    • Green, Cynthia L., Paul Kligfield, Samuel George, Ihor Gussak, Branislav Vajdic, Philip Sager, and Mitchell W. Krucoff. “Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database.” Am Heart J 163, no. 3 (March 2012): 365–71. https://doi.org/10.1016/j.ahj.2011.11.009.
       Full Text  Link to Item
    • Tsujino, Ichizo, Tomomi Koizumi, Takao Shimohama, Junya Ako, Katsuhisa Waseda, Mitchell Krucoff, Yasuhiro Honda, and Peter J. Fitzgerald. “Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents.” Cardiovasc Revasc Med 13, no. 2 (March 2012): 111–18. https://doi.org/10.1016/j.carrev.2012.01.010.
       Full Text  Link to Item
    • Ho, Tony W., Andrew P. Ho, Bernard R. Chaitman, Constance Johnson, Ninan T. Mathew, James Kost, Xiaoyin Fan, et al. “Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.” Headache 52, no. 2 (February 2012): 224–35. https://doi.org/10.1111/j.1526-4610.2011.02052.x.
       Full Text  Link to Item
    • Krucoff, Mitchell W., David R. Rutledge, Luis Gruberg, Lalitha Jonnavithula, John N. Katopodis, William Lombardi, Vivian W. Mao, et al. “A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study).” Jacc Cardiovasc Interv 4, no. 12 (December 2011): 1298–1309. https://doi.org/10.1016/j.jcin.2011.08.010.
       Full Text  Link to Item
    • Kuijt, Wichert J., Mitchell W. Krucoff, Peter Damman, Renato D. Lopes, Cindy L. Green, Karen S. Pieper, Susanna R. Stevens, et al. “Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.” Circulation 124, no. 21 (November 22, 2011).
       Link to Item
    • Cutlip, D. E., M. W. Krucoff, R. Mehran, and R. Virmani. “Reply.” Jacc: Cardiovascular Interventions 4, no. 10 (October 1, 2011): 1151–52. https://doi.org/10.1016/j.jcin.2011.08.006.
       Full Text
    • Leder, Drew, and Mitchell W. Krucoff. “Toward a more materialistic medicine: the value of authentic materialism within current and future medical practice.” J Altern Complement Med 17, no. 9 (September 2011): 859–65. https://doi.org/10.1089/acm.2010.0766.
       Full Text  Link to Item
    • Saito, Shigeru, Ross Prpic, Jeffery J. Popma, John Alexander, Mitchell W. Krucoff, and Mitchell W. ENDEAVOR Japan Investigators. “The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients with de novo native coronary artery lesions: primary results and 3-year follow-up of the Endeavor Japan study.” Cardiovasc Revasc Med 12, no. 5 (September 2011): 273–79. https://doi.org/10.1016/j.carrev.2010.12.007.
       Full Text  Link to Item
    • Krucoff, Mitchell W., W Schuyler Jones, and Manesh R. Patel. “Learning to walk before we run: the mechanics of medical intervention for peripheral arterial disease.” J Am Coll Cardiol 58, no. 10 (August 30, 2011): 1077–79. https://doi.org/10.1016/j.jacc.2011.04.035.
       Full Text  Link to Item
    • Fraser, Alan G., Jean-Claude Daubert, Frans Van de Werf, NA Mark Estes, Sidney C. Smith, Mitchell W. Krucoff, Panos E. Vardas, Michel Komajda, and Michel participants. “Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.” Eur Heart J 32, no. 13 (July 2011): 1673–86. https://doi.org/10.1093/eurheartj/ehr171.
       Full Text  Link to Item
    • Newby, L Kristin, Ignacio Rodriguez, John Finkle, Richard C. Becker, Karen A. Hicks, Elizabeth Hausner, Ruth Chesler, et al. “Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration.” Am Heart J 162, no. 1 (July 2011): 64–73. https://doi.org/10.1016/j.ahj.2011.04.005.
       Full Text  Link to Item
    • Mehran, Roxana, Sunil V. Rao, Deepak L. Bhatt, C Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, et al. “Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.” Circulation 123, no. 23 (June 14, 2011): 2736–47. https://doi.org/10.1161/CIRCULATIONAHA.110.009449.
       Full Text  Link to Item
    • Behm, Martin O., Rebecca L. Blanchard, M Gail Murphy, John S. Palcza, Dawn E. Harris, Kristin L. Butterfield, William B. Smith, Richard A. Preston, Jeffrey A. Chodakewitz, and Mitchell W. Krucoff. “Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.” Headache 51, no. 6 (June 2011): 954–60. https://doi.org/10.1111/j.1526-4610.2011.01901.x.
       Full Text  Link to Item
    • Fraser, Alan G., Mitchell W. Krucoff, Ralph G. Brindis, Michel Komajda, and Sidney C. Smith. “Commentary: International collaboration needed on device clinical standards.” Bmj 342 (May 13, 2011): d2952. https://doi.org/10.1136/bmj.d2952.
       Full Text  Link to Item
    • Cutlip, Donald E., Gaku Nakazawa, Mitchell W. Krucoff, Marc Vorpahl, Roxana Mehran, Aloke V. Finn, Pascal Vranckx, et al. “Autopsy validation study of the academic research consortium stent thrombosis definition.” Jacc Cardiovasc Interv 4, no. 5 (May 2011): 554–59. https://doi.org/10.1016/j.jcin.2011.01.011.
       Full Text  Link to Item
    • Krucoff, M. “Focus on the cardiac safety research consortium.” Drug Information Journal 45, no. 3 (May 1, 2011): 241–44. https://doi.org/10.1177/009286151104500304.
       Full Text
    • Krucoff, Mitchell W., Roxana Mehran, Gerrit-Anne van Es, Ashley B. Boam, and Donald E. Cutlip. “The academic research consortium governance charter.” Jacc Cardiovasc Interv 4, no. 5 (May 2011): 595–96. https://doi.org/10.1016/j.jcin.2011.03.008.
       Full Text  Link to Item
    • Di Mario, Carlo. “Differences in the approval process for interventional devices in Europe and USA: IN MEDIO STAT VIRTUS.” Eurointervention 6, no. 8 (March 2011): 913–17. https://doi.org/10.4244/EIJV6I8A159.
       Full Text  Link to Item
    • Rao, Sunil V., and Mitchell W. Krucoff. “Transradial PCI in women: problem solved or clinical equipoise?” J Invasive Cardiol 23, no. 3 (March 2011): 4ppreceding101.
       Link to Item
    • Gu, Youlan L., Joost D. E. Haeck, Mathijs Vogelzang, Luc Bilodeau, Mitchell W. Krucoff, Jan G. P. Tijssen, Robbert J. de Winter, Felix Zijlstra, and Karel T. Koch. “Computer-assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast-enhanced cardiovascular magnetic resonance outcomes in patients with ST-segment elevation myocardial infarction.” Catheter Cardiovasc Interv 77, no. 2 (February 1, 2011): 174–81. https://doi.org/10.1002/ccd.22665.
       Full Text  Link to Item
    • Leon, Martin B., Nicolo Piazza, Eugenia Nikolsky, Eugene H. Blackstone, Donald E. Cutlip, Arie Pieter Kappetein, Mitchell W. Krucoff, et al. “Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.” J Am Coll Cardiol 57, no. 3 (January 18, 2011): 253–69. https://doi.org/10.1016/j.jacc.2010.12.005.
       Full Text  Link to Item
    • Haeck, Joost D. E., Niels J. W. Verouden, Wichert J. Kuijt, Karel T. Koch, Mohamed Majidi, Alexander Hirsch, Jan G. P. Tijssen, Mitchell W. Krucoff, and Robbert J. De Winter. “Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging.” J Electrocardiol 44, no. 1 (January 2011): 36–41. https://doi.org/10.1016/j.jelectrocard.2010.08.004.
       Full Text  Link to Item
    • Leon, Martin B., Nicolo Piazza, Eugenia Nikolsky, Eugene H. Blackstone, Donald E. Cutlip, Arie Pieter Kappetein, Mitchell W. Krucoff, et al. “Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.” Eur Heart J 32, no. 2 (January 2011): 205–17. https://doi.org/10.1093/eurheartj/ehq406.
       Full Text  Link to Item
    • Rao, S. V., and M. W. Krucoff. “Transradial PCI in women: Problem solved or clinical equipoise?” Journal of Invasive Cardiology 23, no. 3 (January 1, 2011): 98–99.
    • Kligfield, Paul, Cynthia L. Green, Justin Mortara, Philip Sager, Norman Stockbridge, Michael Li, Joanne Zhang, et al. “The Cardiac Safety Research Consortium electrocardiogram warehouse: thorough QT database specifications and principles of use for algorithm development and testing.” Am Heart J 160, no. 6 (December 2010): 1023–28. https://doi.org/10.1016/j.ahj.2010.09.002.
       Full Text  Link to Item
    • Haeck, J. D. E., K. T. Koch, Y. L. Gu, L. Bilodeau, W. J. Kuijt, K. D. Sjauw, J. P. S. Henriques, et al. “Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial.” Neth Heart J 18, no. 11 (November 2010): 531–36. https://doi.org/10.1007/s12471-010-0829-7.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Hugh Calkins, Benjamin C. Eloff, Peter Kowey, Stephen C. Hammill, Kenneth A. Ellenbogen, Danica Marinac-Dabic, et al. “Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank.” Am Heart J 160, no. 4 (October 2010): 619–26. https://doi.org/10.1016/j.ahj.2010.06.044.
       Full Text  Link to Item
    • Rodriguez, Ignacio, Andrew Erdman, Desmond Padhi, Christine E. Garnett, Hong Zhao, Shari L. Targum, Suchitra Balakrishnan, et al. “Electrocardiographic assessment for therapeutic proteins--scientific discussion.” Am Heart J 160, no. 4 (October 2010): 627–34. https://doi.org/10.1016/j.ahj.2010.07.001.
       Full Text  Link to Item
    • O’Neil, Brian J., James Hoekstra, Yuri B. Pride, Cedric Lefebvre, Deborah Diercks, W. Frank Peacock, Gregory J. Fermann, et al. “Incremental benefit of 80-lead electrocardiogram body surface mapping over the 12-lead electrocardiogram in the detection of acute coronary syndromes in patients without ST-elevation myocardial infarction: Results from the Optimal Cardiovascular Diagnostic Evaluation Enabling Faster Treatment of Myocardial Infarction (OCCULT MI) trial.” Acad Emerg Med 17, no. 9 (September 2010): 932–39. https://doi.org/10.1111/j.1553-2712.2010.00848.x.
       Full Text  Link to Item
    • Krucoff, Carol, Kimberly Carson, Matthew Peterson, Kathy Shipp, and Mitchell Krucoff. “Teaching yoga to seniors: essential considerations to enhance safety and reduce risk in a uniquely vulnerable age group.” J Altern Complement Med 16, no. 8 (August 2010): 899–905. https://doi.org/10.1089/acm.2009.0501.
       Full Text  Open Access Copy  Link to Item
    • Min, Sherene S., J Rick Turner, Adel Nada, Tara L. DiMino, Ivo Hynie, Robert Kleiman, Peter Kowey, et al. “Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development.” Am Heart J 159, no. 5 (May 2010): 716–29. https://doi.org/10.1016/j.ahj.2010.02.004.
       Full Text  Link to Item
    • Kong, David F., Vic Hasselblad, and Mitchell W. Krucoff. “Evidence strength in FDA premarket approval of cardiovascular devices.” Jama 303, no. 16 (April 28, 2010): 1599–1600. https://doi.org/10.1001/jama.2010.511.
       Full Text  Link to Item
    • Haeck, Joost D. E., Niels J. W. Verouden, Wichert J. Kuijt, Karel T. Koch, Jan P. Van Straalen, Johan Fischer, Maarten Groenink, et al. “Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.” Am J Cardiol 105, no. 8 (April 15, 2010): 1065–69. https://doi.org/10.1016/j.amjcard.2009.12.003.
       Full Text  Link to Item
    • Haeck, Joost D. E., Youlan L. Gu, Mathijs Vogelzang, Luc Bilodeau, Mitchell W. Krucoff, Jan G. P. Tijssen, Robbert J. De Winter, Felix Zijlstra, and Karel T. Koch. “Feasibility and applicability of computer-assisted myocardial blush quantification after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.” Catheter Cardiovasc Interv 75, no. 5 (April 1, 2010): 701–6. https://doi.org/10.1002/ccd.22329.
       Full Text  Link to Item
    • Petersen, John L., John J. Barron, Bradley G. Hammill, Mark J. Cziraky, Kevin J. Anstrom, Peter M. Wahl, Eric L. Eisenstein, et al. “Clopidogrel use and clinical events after drug-eluting stent implantation: findings from the HealthCore Integrated Research Database.” Am Heart J 159, no. 3 (March 2010): 462-470.e1. https://doi.org/10.1016/j.ahj.2009.11.031.
       Full Text  Link to Item
    • Haeck, J. D., W. J. Kuijt, K. T. Koch, L. Bilodeau, J. P. Henriques, W. J. Rohling, J. Baan, et al. “Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.” Heart 96, no. 3 (February 2010): 190–95. https://doi.org/10.1136/hrt.2009.180448.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Hugh Calkins, Benjamin C. Eloff, Douglas L. Packer, Kenneth A. Ellenbogen, Stephen C. Hammill, Andrea Natale, et al. “Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank.” Am Heart J 159, no. 1 (January 2010): 17–24. https://doi.org/10.1016/j.ahj.2009.10.018.
       Full Text  Link to Item
    • Lemmert, Miguel E., Mohamed Majidi, Mitchell W. Krucoff, Sebastiaan C. A. M. Bekkers, Harry J. G. M. Crijns, Hein J. J. Wellens, Andrzej S. Kosinski, and Anton P. M. Gorgels. “RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction.” Heart Rhythm 7, no. 1 (January 2010): 65–71. https://doi.org/10.1016/j.hrthm.2009.09.024.
       Full Text  Link to Item
    • Hoekstra, James W., Brian J. O’Neill, Yuri B. Pride, Cedric Lefebvre, Deborah B. Diercks, W Frank Peacock, Gregory J. Fermann, et al. “Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial.” Ann Emerg Med 54, no. 6 (December 2009): 779-788.e1. https://doi.org/10.1016/j.annemergmed.2009.06.525.
       Full Text  Link to Item
    • Krucoff, Mitchell W., and Suzanne W. Crater. “What do "we" want and need to know about prayer and healing?” J Altern Complement Med 15, no. 12 (December 2009): 1259–61. https://doi.org/10.1089/acm.2009.0675.
       Full Text  Link to Item
    • Krucoff, Mitchell W. “From ST-elevation myocardial infarction to ST elevation with no myocardial infarction--review and overview of a new horizon of computerized electrocardiographic ischemia detection using high-fidelity implantable devices.” J Electrocardiol 42, no. 6 (November 2009): 487–93. https://doi.org/10.1016/j.jelectrocard.2009.06.015.
       Full Text  Link to Item
    • Haeck, Joost D. E., Karel T. Koch, Luc Bilodeau, René J. Van der Schaaf, José P. S. Henriques, Marije M. Vis, Jan Baan, et al. “Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study.” Jacc Cardiovasc Interv 2, no. 10 (October 2009): 934–43. https://doi.org/10.1016/j.jcin.2009.07.013.
       Full Text  Link to Item
    • Stone, Gregg W., Jack L. Martin, Menko-Jan de Boer, Massimo Margheri, Ezio Bramucci, James C. Blankenship, D Christopher Metzger, et al. “Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.” Circ Cardiovasc Interv 2, no. 5 (October 2009): 366–75. https://doi.org/10.1161/CIRCINTERVENTIONS.108.840066.
       Full Text  Link to Item
    • Nikolsky, Eugenia, Gregg W. Stone, Edwin Lee, Alexandra J. Lansky, John Webb, David A. Cox, Bruce R. Brodie, et al. “Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial.” Eurointervention 5, no. 4 (September 2009): 417–24. https://doi.org/10.4244/eijv5i4a66.
       Full Text  Link to Item
    • Piccini, Jonathan P., David J. Whellan, Brian R. Berridge, John K. Finkle, Syril D. Pettit, Norman Stockbridge, Jean-Pierre Valentin, Hugo M. Vargas, Mitchell W. Krucoff, and Mitchell W. CSRC/HESI Writing Group. “Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.” Am Heart J 158, no. 3 (September 2009): 317–26. https://doi.org/10.1016/j.ahj.2009.06.007.
       Full Text  Link to Item
    • Waxman, Sergio, Simon R. Dixon, Philippe L’Allier, Jeffrey W. Moses, John L. Petersen, Donald Cutlip, Jean-Claude Tardif, et al. “In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.” Jacc Cardiovasc Imaging 2, no. 7 (July 2009): 858–68. https://doi.org/10.1016/j.jcmg.2009.05.001.
       Full Text  Link to Item
    • Whellan, D. J., C. L. Green, J. P. Piccini, and M. W. Krucoff. “QT as a safety biomarker in drug development.” Clin Pharmacol Ther 86, no. 1 (July 2009): 101–4. https://doi.org/10.1038/clpt.2009.70.
       Full Text  Link to Item
    • Mitchell, W. K. “Healing hearts with noetics: An interview with, M.D., F.A.C.C., F.C.C.P.” Alternative and Complementary Therapies 15, no. 3 (June 1, 2009): 142–46. https://doi.org/10.1089/act.2009.15301.
       Full Text
    • Finkle, John, Daniel Bloomfield, Kathleen Uhl, Wendy Sanhai, Norman Stockbridge, and Mitchell W. Krucoff. “New precompetitive paradigms: focus on cardiac safety.” Am Heart J 157, no. 5 (May 2009): 825–26. https://doi.org/10.1016/j.ahj.2009.02.021.
       Full Text  Link to Item
    • Tzivoni, Dan, and Mitchell W. Krucoff. “Continuous ST-segment monitoring in contemporary acute coronary syndrome patients: the magic of MERLIN-TIMI 36.” J Am Coll Cardiol 53, no. 16 (April 21, 2009): 1422–24. https://doi.org/10.1016/j.jacc.2009.01.039.
       Full Text  Link to Item
    • Majidi, Mohamed, Andrzej S. Kosinski, Sana M. Al-Khatib, Miguel E. Lemmert, Lilian Smolders, Anton van Weert, Johan H. C. Reiber, et al. “Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction.” Eur Heart J 30, no. 7 (April 2009): 757–64. https://doi.org/10.1093/eurheartj/ehp005.
       Full Text  Link to Item
    • Petersen, John L., John D. Barron, Bradley G. Hammill, Mark J. Cziraky, Kevin J. Anstrom, Peter M. Wahl, Eric J. Eisenstein, et al. “Clopidogrel Use and Clinical Events After Drug-Eluting Stent Implantation: Findings From the HealthCore Integrated Research Database.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A11–12.
       Link to Item
    • Smolders, L., M. Majidi, M. W. Krucoff, H. J. G. M. Crijns, H. J. J. Wellens, and A. P. M. Gorgels. “Reporting an Erratum in the article, "Preexcitation and Myocardial Infarction: Conditions with Confusing Electrocardiographic Manifestations", November/December issue (41/6) (DOI:10.1016/j.jelectrocard.2008.05.005).” Journal of Electrocardiology 42, no. 2 (March 1, 2009): 189. https://doi.org/10.1016/j.jelectrocard.2008.12.021.
       Full Text
    • Daemen, Joost, Maarten L. Simoons, William Wijns, Adrian Bagust, Gert Bos, James M. Bowen, Eugene Braunwald, et al. “Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.” Eurointervention 4, no. 4 (January 2009): 427–36.
       Link to Item
    • Daemen, Joost, Maarten L. Simoons, William Wijns, Adrian Bagust, Gert Bos, James M. Bowen, Eugene Braunwald, et al. “ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.” Eur Heart J 30, no. 2 (January 2009): 152–61. https://doi.org/10.1093/eurheartj/ehn510.
       Full Text  Link to Item
    • Sullivan, Martin J., Laura Wood, Jennifer Terry, Jeff Brantley, Ann Charles, Vicky McGee, Diane Johnson, et al. “The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure.” Am Heart J 157, no. 1 (January 2009): 84–90. https://doi.org/10.1016/j.ahj.2008.08.033.
       Full Text  Link to Item
    • Albertal, Mariano, Fernando Cura, Mitchell W. Krucoff, Ricardo Baeza, Alejandro Garcia Escudero, Lucio T. Padilla, Jorge Thierer, et al. “Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis.” Int J Cardiol 130, no. 2 (November 12, 2008): 220–26. https://doi.org/10.1016/j.ijcard.2007.08.085.
       Full Text  Link to Item
    • Smolders, Lilian, Mohamed Majidi, Mitchell W. Krucoff, Harry J. G. M. Crijns, Hein J. J. Wellens, and Anton P. M. Gorgels. “Preexcitation and myocardial infarction: conditions with confusing electrocardiographic manifestations.” J Electrocardiol 41, no. 6 (November 2008): 679–82. https://doi.org/10.1016/j.jelectrocard.2008.05.005.
       Full Text  Link to Item
    • De Carlo, Marco, David A. Wood, John G. Webb, Ulrich Gerckens, Bernardo Cortese, Eberhard Grube, GB John Mancini, et al. “Adjunctive use of the Rinspiration system for fluidic thrombectomy during primary angioplasty: the Rinspiration international registry.” Catheter Cardiovasc Interv 72, no. 2 (August 1, 2008): 196–203. https://doi.org/10.1002/ccd.21596.
       Full Text  Link to Item
    • Majidi, Mohamed, Andrzej S. Kosinski, Sana M. Al-Khatib, Miguel E. Lemmert, Lilian Smolders, Anton van Weert, Johan H. C. Reiber, et al. “Reperfusion ventricular arrhythmia 'bursts' in TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction: a more precise definition of reperfusion arrhythmias.” Europace 10, no. 8 (August 2008): 988–97. https://doi.org/10.1093/europace/eun123.
       Full Text  Link to Item
    • Rao, Sunil V., Robert M. Califf, Judith M. Kramer, Eric D. Peterson, Thomas P. Gross, Carl J. Pepine, David O. Williams, et al. “Postmarket evaluation of breakthrough technologies.” Am Heart J 156, no. 2 (August 2008): 201–8. https://doi.org/10.1016/j.ahj.2008.01.036.
       Full Text  Link to Item
    • Kereiakes, Dean J., John L. Petersen, Wayne B. Batchelor, Peter J. Fitzgerald, Roxana Mehran, Alexandra Lansky, Ichizo Tsujino, et al. “Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial.” J Invasive Cardiol 20, no. 7 (July 2008): 335–41.
       Link to Item
    • Dangas, George, Gregg W. Stone, Mitchell D. Weinberg, John Webb, David A. Cox, Bruce R. Brodie, Mitchell W. Krucoff, et al. “Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial).” Am Heart J 155, no. 6 (June 2008): 1090–96. https://doi.org/10.1016/j.ahj.2007.12.003.
       Full Text  Link to Item
    • Nelwan, Stefan P., Jan A. Kors, Suzanne W. Crater, Simon H. Meij, Teus B. van Dam, Maarten L. Simoons, and Mitchell W. Krucoff. “Simultaneous comparison of 3 derived 12-lead electrocardiograms with standard electrocardiogram at rest and during percutaneous coronary occlusion.” J Electrocardiol 41, no. 3 (May 2008): 230–37. https://doi.org/10.1016/j.jelectrocard.2008.01.011.
       Full Text  Link to Item
    • Krucoff, Mitchell W., Dean J. Kereiakes, John L. Petersen, Roxana Mehran, Vic Hasselblad, Alexandra J. Lansky, Peter J. Fitzgerald, et al. “A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.” J Am Coll Cardiol 51, no. 16 (April 22, 2008): 1543–52. https://doi.org/10.1016/j.jacc.2008.01.020.
       Full Text  Link to Item
    • Leder, Drew, and Mitchell W. Krucoff. “The touch that heals: the uses and meanings of touch in the clinical encounter.” J Altern Complement Med 14, no. 3 (April 2008): 321–27. https://doi.org/10.1089/acm.2007.0717.
       Full Text  Link to Item
    • Lemmert, Miguel E., Jonas S. S. G. de Jong, Antonius M. W. van Stipdonk, Harry J. G. M. Crijns, Hein J. J. Wellens, Mitchell W. Krucoff, Lukas R. Dekker, Arthur A. M. Wilde, and Anton P. M. Gorgels. “Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery.” Heart Rhythm 5, no. 1 (January 2008): 71–78. https://doi.org/10.1016/j.hrthm.2007.09.011.
       Full Text  Link to Item
    • Kostic, M. N., S. Fakhar, T. Foxall, B. S. Drakulic, and M. W. Krucoff. “Evaluation of novel ECG signal processing on quantification of transient ischemia and baseline wander suppression.” Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Conference, December 1, 2007, 2199–2202.
    • Kereiakes, Dean J., Paul S. Teirstein, Ian J. Sarembock, David R. Holmes, Mitchell W. Krucoff, William W. O’Neill, Ron Waksman, et al. “The truth and consequences of the COURAGE trial.” J Am Coll Cardiol 50, no. 16 (October 16, 2007): 1598–1603. https://doi.org/10.1016/j.jacc.2007.07.063.
       Full Text  Link to Item
    • Majidi, Mohamed, Andrzej S. Kosinski, Sana M. Al-Khatib, Lilian Smolders, Miguel E. Lemmert, Karen S. Pieper, Harry J. Crijns, Hein J. Wellens, Anton P. Gorgels, and Mitchell W. Krucoff. “Mechanistic and prognostic implications of "Burst" ventricular arrhythmias and their precise timing after TIMI 3 reperfusion in anterior ST elevation myocardial infarction.” Circulation 116, no. 16 (October 16, 2007): 440–440.
       Link to Item
    • Sorajja, Paul, Bernard J. Gersh, Roxana Mehran, Alexandra J. Lansky, Mitchell W. Krucoff, John Webb, David A. Cox, Bruce R. Brodie, and Gregg W. Stone. “Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction.” Am Heart J 154, no. 2 (August 2007): 379–84. https://doi.org/10.1016/j.ahj.2007.04.034.
       Full Text  Link to Item
    • O’Neill, William W., Jack L. Martin, Simon R. Dixon, Antonio L. Bartorelli, Daniela Trabattoni, Pranobe V. Oemrawsingh, Douwe E. Atsma, et al. “Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.” J Am Coll Cardiol 50, no. 5 (July 31, 2007): 397–405. https://doi.org/10.1016/j.jacc.2007.01.099.
       Full Text  Link to Item
    • Marso, Steven P., Todd Miller, Barry D. Rutherford, Raymond J. Gibbons, Mansoor Qureshi, Anna Kalynych, Mark Turco, et al. “Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).” Am J Cardiol 100, no. 2 (July 15, 2007): 206–10. https://doi.org/10.1016/j.amjcard.2007.02.080.
       Full Text  Link to Item
    • Holmes, David R., Dean J. Kereiakes, Warren K. Laskey, Antonio Colombo, Stephen G. Ellis, Timothy D. Henry, Jeffrey J. Popma, et al. “Thrombosis and drug-eluting stents: an objective appraisal.” J Am Coll Cardiol 50, no. 2 (July 10, 2007): 109–18. https://doi.org/10.1016/j.jacc.2007.04.032.
       Full Text  Link to Item
    • Brodie, Bruce R., John Webb, David A. Cox, Mansoor Qureshi, Anna Kalynych, Mark Turco, Heinz P. Schultheiss, et al. “Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).” Am J Cardiol 99, no. 12 (June 15, 2007): 1680–86. https://doi.org/10.1016/j.amjcard.2007.01.047.
       Full Text  Link to Item
    • Krucoff, Mitchell W., Ashley Boam, and Daniel G. Schultz. “Drug-eluting stents "deliver heartburn": how do we spell relief going forward?” Circulation 115, no. 23 (June 12, 2007): 2990–94. https://doi.org/10.1161/CIRCULATIONAHA.107.707778.
       Full Text  Link to Item
    • Cutlip, Donald E., Stephan Windecker, Roxana Mehran, Ashley Boam, David J. Cohen, Gerrit-Anne van Es, P Gabriel Steg, et al. “Clinical end points in coronary stent trials: a case for standardized definitions.” Circulation 115, no. 17 (May 1, 2007): 2344–51. https://doi.org/10.1161/CIRCULATIONAHA.106.685313.
       Full Text  Link to Item
    • Krucoff, C., and M. Krucoff. “'Till death do us part?” Alternative Medicine, no. 97 (May 1, 2007): 64–70.
    • Wang, Tracy Y., Vic Hasselblad, John L. Peterson, William Wijns, Azin Parhizgar, Dean J. Kereiakes, and Mitchell W. Krucoff. “The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents.” Am Heart J 153, no. 5 (May 2007): 743–48. https://doi.org/10.1016/j.ahj.2007.02.015.
       Full Text  Link to Item
    • Cura, Fernando A., Alejandro Garcia Escudero, Daniel Berrocal, Oscar Mendiz, Marcelo S. Trivi, Juan Fernandez, Alejandro Palacios, et al. “Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR).” Am J Cardiol 99, no. 3 (February 1, 2007): 357–63. https://doi.org/10.1016/j.amjcard.2006.08.038.
       Full Text  Link to Item
    • Hasselblad, V., Y. Lokhnygina, and M. W. Krucoff. “Discussion of: Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studies.” Journal of Biopharmaceutical Statistics 17, no. 1 (January 1, 2007): 19–21. https://doi.org/10.1080/10543400601044725.
       Full Text
    • Kostic, M. N., S. Fakhar, T. Foxall, B. S. Drakulic, and M. W. Krucoff. “Evaluation of novel ECG signal processing on quantification of transient ischemia and baseline wander suppression.” Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Conference 2007 (2007): 2199–2202.
    • Kostic, Marko N., Sina Fakhar, Tom Foxall, Budimir S. Drakulic, and Mitchell W. Krucoff. “Evaluation of novel ECG signal processing on quantification of transient ischemia and baseline wander suppression.” Annu Int Conf Ieee Eng Med Biol Soc 2007 (2007): 2199–2202. https://doi.org/10.1109/IEMBS.2007.4352760.
       Full Text  Link to Item
    • Sanhai, Wendy R., Norman Stockbridge, Robert P. Fiorentino, Takahiro Uchida, Kathleen Uhl, and Mitch W. Krucoff. “Drug eluting stents and the critical path initiative: Evolving paradigms for safety evaluation.” Drug Discov Today Technol 4, no. 2 (2007): 43–46. https://doi.org/10.1016/j.ddtec.2007.10.004.
       Full Text  Link to Item
    • Fischell, Tim A., David R. Fischell, Robert E. Fischell, Renu Virmani, Jennifer J. DeVries, and Mitchell W. Krucoff. “Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model.” J Am Coll Cardiol 48, no. 11 (December 5, 2006): 2306–14. https://doi.org/10.1016/j.jacc.2006.07.058.
       Full Text  Link to Item
    • Wijns, William C., and Mitchell W. Krucoff. “Increased mortality after implantation of first generation drug-eluting stents: seeing the smoke, where is the fire?” Eur Heart J 27, no. 23 (December 2006): 2737–39. https://doi.org/10.1093/eurheartj/ehl378.
       Full Text  Link to Item
    • Bär, Frits W., Dan Tzivoni, Maurits T. Dirksen, Antonio Fernández-Ortiz, Guy R. Heyndrickx, Johannes Brachmann, Johan H. C. Reiber, et al. “Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study.” Eur Heart J 27, no. 21 (November 2006): 2516–23. https://doi.org/10.1093/eurheartj/ehl304.
       Full Text  Link to Item
    • Nilsson, Kent R., Shayar M. Gharacholou, Michael H. Sketch, and Mitchell W. Krucoff. “Simultaneous restenosis of Taxus and Cypher drug-eluting stents.” J Invasive Cardiol 18, no. 11 (November 2006): 557–60.
       Link to Item
    • Drew, Barbara J., Claire E. Sommargren, Daniel M. Schindler, Jessica Zegre, Kent Benedict, and Mitchell W. Krucoff. “Novel electrocardiogram configurations and transmission procedures in the prehospital setting: effect on ischemia and arrhythmia determination.” J Electrocardiol 39, no. 4 Suppl (October 2006): S157–60. https://doi.org/10.1016/j.jelectrocard.2006.05.033.
       Full Text  Link to Item
    • Webb, John, Mann Chandavimol, Jaap N. Hamburger, Gordon Pate, Bruce McManus, Mitch Krucoff, and GB John Mancini. “Initial experience with a novel coronary rinsing and thrombectomy system: "Rinspiration".” J Invasive Cardiol 18, no. 5 (May 2006): 188–92.
       Link to Item
    • Krucoff, Mitchell W., Suzanne W. Crater, and Kerry L. Lee. “From efficacy to safety concerns: a STEP forward or a step back for clinical research and intercessory prayer? The Study of Therapeutic Effects of Intercessory Prayer (STEP).” Am Heart J 151, no. 4 (April 2006): 762–64. https://doi.org/10.1016/j.ahj.2005.06.031.
       Full Text  Link to Item
    • Kereiakes, D. J., R. E. Kuntz, L. Mauri, and M. W. Krucoff. “Reply [10].” Journal of the American College of Cardiology 47, no. 2 (January 17, 2006): 471. https://doi.org/10.1016/j.jacc.2005.10.036.
       Full Text
    • O’Mathúna, D. P., M. W. Krucoff, and S. W. Crater. “Study of prayer and other complementary therapies finds little benefit for cardiac patients.” Focus on Alternative and Complementary Therapies 10, no. 4 (December 1, 2005): 316–18. https://doi.org/10.1211/fact.10.4.0027.
       Full Text
    • McLafferty, Charles, and Anthony Onwuegbuzie. “The MANTRA II study.” Lancet 366, no. 9499 (November 19, 2005): 1769. https://doi.org/10.1016/S0140-6736(05)67718-5.
       Full Text  Link to Item
    • Krucoff, Mitchell W., Suzanne W. Crater, Michael Cuffe, Daniel Mark, and Kerry L. Lee. “The MANTRA II study – Authors' reply.” The Lancet 366, no. 9499 (November 2005): 1770–71. https://doi.org/10.1016/s0140-6736(05)67720-3.
       Full Text
    • Cabell, Christopher H., Tory C. Noto, and Mitchell W. Krucoff. “Clinical utility of the Food and Drug Administration Electrocardiogram Warehouse: a paradigm for the critical pathway initiative.” J Electrocardiol 38, no. 4 Suppl (October 2005): 175–79. https://doi.org/10.1016/j.jelectrocard.2005.06.104.
       Full Text  Link to Item
    • Johanson, Per, Yuling Fu, Shaun G. Goodman, Mikael Dellborg, Paul W. Armstrong, Mitchell W. Krucoff, Lars Wallentin, and Galen S. Wagner. “A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy.” Eur Heart J 26, no. 17 (September 2005): 1726–33. https://doi.org/10.1093/eurheartj/ehi221.
       Full Text  Link to Item
    • Krucoff, Mitchell W., Suzanne W. Crater, Dianne Gallup, James C. Blankenship, Michael Cuffe, Mimi Guarneri, Richard A. Krieger, et al. “Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study.” Lancet 366, no. 9481 (July 16, 2005): 211–17. https://doi.org/10.1016/S0140-6736(05)66910-3.
       Full Text  Link to Item
    • Vogel, John H. K., Steven F. Bolling, Rebecca B. Costello, Erminia M. Guarneri, Mitchell W. Krucoff, John C. Longhurst, Brian Olshansky, et al. “Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine).” J Am Coll Cardiol 46, no. 1 (July 5, 2005): 184–221. https://doi.org/10.1016/j.jacc.2005.05.031.
       Full Text  Link to Item
    • Kereiakes, Dean J., Richard E. Kuntz, Laura Mauri, and Mitchell W. Krucoff. “Surrogates, substudies, and real clinical end points in trials of drug-eluting stents.” J Am Coll Cardiol 45, no. 8 (April 19, 2005): 1206–12. https://doi.org/10.1016/j.jacc.2005.01.005.
       Full Text  Link to Item
    • Stone, Gregg W., John Webb, David A. Cox, Bruce R. Brodie, Mansoor Qureshi, Anna Kalynych, Mark Turco, et al. “Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.” Jama 293, no. 9 (March 2, 2005): 1063–72. https://doi.org/10.1001/jama.293.9.1063.
       Full Text  Link to Item
    • Drew, Barbara J., Robert M. Califf, Marjorie Funk, Elizabeth S. Kaufman, Mitchell W. Krucoff, Michael M. Laks, Peter W. Macfarlane, et al. “AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized electrocardiology and the American Association of Critical-Care Nurses.” J Cardiovasc Nurs 20, no. 2 (March 2005): 76–106. https://doi.org/10.1097/00005082-200503000-00003.
       Full Text  Link to Item
    • Rebeiz, Abdallah G., Per Johanson, Cindy L. Green, Suzanne W. Crater, Matthew T. Roe, Anatoly Langer, Robert P. Giugliano, et al. “Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).” Am J Cardiol 95, no. 5 (March 1, 2005): 611–14. https://doi.org/10.1016/j.amjcard.2004.10.038.
       Full Text  Link to Item
    • Fischell, Tim A., David R. Fischell, Robert E. Fischell, Susan Baskerville, Susan Hendrick, Carol Moshier, Jonathan P. Harwood, and Mitchell W. Krucoff. “Potential of an intracardiac electrogram for the rapid detection of coronary artery occlusion.” Cardiovasc Revasc Med 6, no. 1 (January 2005): 14–20. https://doi.org/10.1016/j.carrev.2005.05.002.
       Full Text  Link to Item
    • Johanson, P., P. W. Armstrong, N. A. Barbagelata, B. S. Chaitman, P. Clemmensen, M. Dellborg, J. French, et al. “An academic ECG core lab perspective of the FDA initiative for digital ECG capture and data management in large-scale clinical trials.” Drug Information Journal 39, no. 4 (2005): 345–51.
    • Krucoff, Mitchell W., Per Johanson, Ricardo Baeza, Suzanne W. Crater, and Mikael Dellborg. “Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion.” Circulation 110, no. 25 (December 21, 2004): e533–39. https://doi.org/10.1161/01.CIR.0000150401.54856.D3.
       Full Text  Link to Item
    • Nelwan, Stefan P., Suzanne W. Crater, Cynthia L. Green, Per Johanson, Teus B. van Dam, Simon H. Meij, Maarten L. Simoons, and Mitchell W. Krucoff. “Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia.” Am J Cardiol 94, no. 12 (December 15, 2004): 1529–33. https://doi.org/10.1016/j.amjcard.2004.08.031.
       Full Text  Link to Item
    • Yager, J. E. E., J. A. Dusek, S. W. Crater, and M. W. Krucoff. “Prayer and Cardiovascular Disease,” November 5, 2004, 350–61. https://doi.org/10.1016/B978-0-323-03002-1.50026-4.
       Full Text
    • Drew, Barbara J., Robert M. Califf, Marjorie Funk, Elizabeth S. Kaufman, Mitchell W. Krucoff, Michael M. Laks, Peter W. Macfarlane, et al. “Practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses.” Circulation 110, no. 17 (October 26, 2004): 2721–46. https://doi.org/10.1161/01.CIR.0000145144.56673.59.
       Full Text  Link to Item
    • Gibson, C Michael, Juhana Karha, Robert P. Giugliano, Mathew T. Roe, Sabina A. Murphy, Robert A. Harrington, Cindy L. Green, et al. “Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction.” Am Heart J 147, no. 5 (May 2004): 847–52. https://doi.org/10.1016/j.ahj.2003.11.015.
       Full Text  Link to Item
    • Maas, Arthur C. P., Christina M. Wyatt, Cynthia L. Green, Galen S. Wagner, Kathleen M. Trollinger, James E. Pope, Anatoly Langer, et al. “Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction.” Am Heart J 147, no. 4 (April 2004): 698–704. https://doi.org/10.1016/j.ahj.2003.08.014.
       Full Text  Link to Item
    • Kandzari, David E., Alan Chu, Bruce R. Brodie, Thomas A. Stuckey, James B. Hermiller, George W. Vetrovec, Karen L. Hannan, et al. “Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).” Am J Cardiol 93, no. 5 (March 1, 2004): 636–39. https://doi.org/10.1016/j.amjcard.2003.11.038.
       Full Text  Link to Item
    • Seskevich, Jon E., Suzanne W. Crater, James D. Lane, and Mitchell W. Krucof. “Beneficial effects of noetic therapies on mood before percutaneous intervention for unstable coronary syndromes.” Nurs Res 53, no. 2 (March 2004): 116–21. https://doi.org/10.1097/00006199-200403000-00007.
       Full Text  Link to Item
    • Roe, Matthew T., Cynthia L. Green, Robert P. Giugliano, C Michael Gibson, Kenneth Baran, Mark Greenberg, Sebastian T. Palmeri, et al. “Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.” J Am Coll Cardiol 43, no. 4 (February 18, 2004): 549–56. https://doi.org/10.1016/j.jacc.2003.09.039.
       Full Text  Link to Item
    • Drew, Barbara J., Elise D. Dempsey, Tae H. Joo, Claire E. Sommargren, James P. Glancy, Kent Benedict, and Mitchell W. Krucoff. “Pre-hospital synthesized 12-lead ECG ischemia monitoring with trans-telephonic transmission in acute coronary syndromes: pilot study results of the ST SMART trial.” J Electrocardiol 37 Suppl (2004): 214–21. https://doi.org/10.1016/j.jelectrocard.2004.08.060.
       Full Text  Link to Item
    • Krucoff, Mitchell W. “Permanently implantable diagnostic computerized devices: where is the regulatory rar?” J Electrocardiol 37 Suppl (2004): 68–70. https://doi.org/10.1016/j.jelectrocard.2004.08.019.
       Full Text  Link to Item
    • Nelwan, Stephan P., Suzanne W. Crater, Simon H. Meij, Teus B. van Dam, Jan A. Kors, Maarten L. Simoons, and Mitchell W. Krucoff. “Simultaneous comparison of three derived 12-lead ECGs with standard ECG at rest and during percutaneous coronary occlusion.” J Electrocardiol 37 Suppl (2004): 171–72. https://doi.org/10.1016/j.jelectrocard.2004.08.051.
       Full Text  Link to Item
    • Engelen, Domien J., Virginie Gressin, Mitchell W. Krucoff, Dominic A. Theuns, Cindy Green, Emile C. Cheriex, Pierre Maison-Blanche, Willem R. Dassen, Hein J. Wellens, and Anton P. Gorgels. “Usefulness of frequent arrhythmias after epicardial recanalization in anterior wall acute myocardial infarction as a marker of cellular injury leading to poor recovery of left ventricular function.” Am J Cardiol 92, no. 10 (November 15, 2003): 1143–49. https://doi.org/10.1016/j.amjcard.2003.07.020.
       Full Text  Link to Item
    • Grunberg, Gregory E., Suzanne W. Crater, Cynthia L. Green, Jon Seskevich, James D. Lane, Harold G. Koenig, Thomas M. Bashore, Kenneth G. Morris, Daniel B. Mark, and Mitchell W. Krucoff. “Correlations between preprocedure mood and clinical outcome in patients undergoing coronary angioplasty.” Cardiol Rev 11, no. 6 (November 2003): 309–17. https://doi.org/10.1097/01.crd.0000089947.20354.d5.
       Full Text  Link to Item
    • Jurlander, Birgit, Lene Holmvang, Søren Galatius, Creighton Vaught, Per Johanson, Mitchell W. Krucoff, Peer Grande, Peter Clemmensen, and Galen S. Wagner. “"Mirror-lake" serial relationship of electrocardiographic and biochemical indices for the detection of reperfusion and the prediction of salvage in patients with acute myocardial infarction.” Am Heart J 146, no. 5 (November 2003): 757–63. https://doi.org/10.1016/S0002-8703(03)00394-6.
       Full Text  Link to Item
    • Kandzari, David E., Marino Labinaz, Warren J. Cantor, Mina Madan, Dianne S. Gallup, Vic Hasselblad, Diane Joseph, et al. “Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).” Am J Cardiol 92, no. 6 (September 15, 2003): 660–64. https://doi.org/10.1016/s0002-9149(03)00818-x.
       Full Text  Link to Item
    • Johanson, Per, Galen S. Wagner, Mikael Dellborg, and Mitchell W. Krucoff. “ST-segment monitoring in patients with acute coronary syndromes.” Curr Cardiol Rep 5, no. 4 (July 2003): 278–83. https://doi.org/10.1007/s11886-003-0063-7.
       Full Text  Link to Item
    • Dusek, Jeffery A., John A. Astin, Patricia L. Hibberd, and Mitchell W. Krucoff. “Healing prayer outcomes studies: consensus recommendations.” Altern Ther Health Med 9, no. 3 Suppl (May 2003): A44–53.
       Link to Item
    • Sedlis, Steven P., Douglass A. Morrison, Jeffrey D. Lorin, Rick Esposito, Gulshan Sethi, Jerome Sacks, William Henderson, et al. “Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry.” J Am Coll Cardiol 40, no. 9 (November 6, 2002): 1555–66. https://doi.org/10.1016/s0735-1097(02)02346-x.
       Full Text  Link to Item
    • Theres, Heinz, Robert W. Stadler, Lee Stylos, Martin Glos, Thomas Leuthold, Gert Baumann, Shannon D. Nelson, and Mitchel W. Krucoff. “Comparison of electrocardiogram and intrathoracic electrogram signals for detection of ischemic ST segment changes during normal sinus and ventricular paced rhythms.” J Cardiovasc Electrophysiol 13, no. 10 (October 2002): 990–95. https://doi.org/10.1046/j.1540-8167.2002.00990.x.
       Full Text  Link to Item
    • Wong, C. -. K., J. K. French, M. W. Krucoff, W. Gao, P. E. Aylward, and H. D. White. “Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion.” Eur Heart J 23, no. 18 (September 2002): 1449–55. https://doi.org/10.1053/euhj.2002.3263.
       Full Text  Link to Item
    • Anderson, R David, Harvey D. White, E Magnus Ohman, Galen S. Wagner, Mitchell W. Krucoff, Paul W. Armstrong, W Douglas Weaver, et al. “Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.” Am Heart J 144, no. 1 (July 2002): 81–88. https://doi.org/10.1067/mhj.2002.123319.
       Full Text  Link to Item
    • Morrison, Douglass A., Gulshan Sethi, Jerome Sacks, William Henderson, Frederick Grover, Steven Sedlis, Rick Esposito, et al. “Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial.” J Am Coll Cardiol 39, no. 2 (January 16, 2002): 266–73. https://doi.org/10.1016/s0735-1097(01)01720-x.
       Full Text  Link to Item
    • Booker, Katherine J., Barbara J. Drew, Robert L. Lux, Per Johanson, Mitchell W. Krucoff, David Hampton, Mark Hubelbank, Dirk Q. Feild, Robert W. Stadler, and David M. Mortara. “The first ISCE Board of "Trustees" overview panel session: ischemia monitoring, state of the art. International Society of Computerized Electrocardiology.” J Electrocardiol 35 Suppl (2002): 207–30. https://doi.org/10.1054/jelc.2002.37184.
       Full Text  Link to Item
    • Krucoff, M. W. “Continuous 12-lead ECG monitoring: State of the art.” Journal of Electrocardiology 35, no. SUPPL. (January 1, 2002): 217–20.
    • Krucoff, M. W., S. W. Crater, C. L. Green, A. C. Maas, J. E. Seskevich, J. D. Lane, K. A. Loeffler, K. Morris, T. M. Bashore, and H. G. Koenig. “Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot.” Am Heart J 142, no. 5 (November 2001): 760–69. https://doi.org/10.1067/mhj.2001.119138.
       Full Text  Link to Item
    • Corbalán, R., G. Larrain, C. Nazzal, P. F. Castro, M. Acevedo, J. M. Domínguez, F. Bellolio, and M. W. Krucoff. “Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty.” Am J Cardiol 88, no. 4 (August 15, 2001): 342–46. https://doi.org/10.1016/s0002-9149(01)01676-9.
       Full Text  Link to Item
    • Morrison, D. A., G. Sethi, J. Sacks, W. Henderson, F. Grover, S. Sedlis, R. Esposito, et al. “Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME).” J Am Coll Cardiol 38, no. 1 (July 2001): 143–49. https://doi.org/10.1016/s0735-1097(01)01366-3.
       Full Text  Link to Item
    • Dixon, D., L. Dixon, P. Pascoe, and J. Wilson. “Chromosomal and nuclear characteristics of deep-sea hydrothermal-vent organisms: Correlates of increased growth rate.” Marine Biology 139, no. 2 (February 13, 2001): 251–55. https://doi.org/10.1007/s002270100564.
       Full Text
    • Krucoff, M. W. “Cyclic coronary flow: defining preinfarction angina at the crossroads of unstable angina and myocardial infarction.” Md Med Suppl (2001): 60–64.
       Link to Item
    • Roe, M. T., E. M. Ohman, A. C. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff. “Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.” J Am Coll Cardiol 37, no. 1 (January 2001): 9–18. https://doi.org/10.1016/s0735-1097(00)01101-3.
       Full Text  Link to Item
    • Gibler, W. B., J. W. Hoekstra, W. D. Weaver, M. W. Krucoff, A. P. Hallstrom, R. E. Jackson, M. R. Sayre, et al. “A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT).” J Am Coll Cardiol 36, no. 5 (November 1, 2000): 1500–1506. https://doi.org/10.1016/s0735-1097(00)00897-4.
       Full Text  Link to Item
    • Krucoff, M. W. “Growing the path to the patient: an editorial outlook for Alternative therapies.” Altern Ther Health Med 6, no. 4 (July 2000): 36–37.
       Link to Item
    • Andrews, J., I. T. Straznicky, J. K. French, C. L. Green, A. C. Maas, M. Lund, M. W. Krucoff, and H. D. White. “ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy.” Circulation 101, no. 18 (May 9, 2000): 2138–43. https://doi.org/10.1161/01.cir.101.18.2138.
       Full Text  Link to Item
    • Akkerhuis, K. M., A. C. Maas, P. A. Klootwijk, M. W. Krucoff, S. Meij, R. M. Califf, and M. L. Simoons. “Recurrent ischemia during continuous 12-lead ECG-ischemia monitoring in patients with acute coronary syndromes treated with eptifibatide: relation with death and myocardial infarction. PURSUIT ECG-Ischemia Monitoring Substudy Investigators. Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy.” J Electrocardiol 33, no. 2 (April 2000): 127–36. https://doi.org/10.1016/s0022-0736(00)80069-2.
       Full Text  Link to Item
    • Crater, S. W., C. A. Taylor, A. C. Maas, A. K. Loeffler, J. E. Pope, B. J. Drew, and M. W. Krucoff. “Real-time application of continuous 12-lead ST-segment monitoring: 3 case studies.” Crit Care Nurse 20, no. 2 (April 2000): 93–99.
       Link to Item
    • Tanguay, J. F., W. J. Cantor, M. W. Krucoff, B. Muhlestein, G. W. Barsness, J. P. Zidar, M. H. Sketch, et al. “Local delivery of heparin post-PTCA: a multicenter randomized pilot study.” Catheter Cardiovasc Interv 49, no. 4 (April 2000): 461–67. https://doi.org/10.1002/(sici)1522-726x(200004)49:4<461::aid-ccd26>3.0.co;2-7.
       Full Text  Link to Item
    • Lubarsky, D. A., S. D. Fisher, T. F. Slaughter, C. L. Green, C. K. Lineberger, J. R. Astles, C. S. Greenberg, W. W. Inge, and M. W. Krucoff. “Myocardial ischemia correlates with reduced fibrinolytic activity following peripheral vascular surgery.” J Clin Anesth 12, no. 2 (March 2000): 136–41. https://doi.org/10.1016/s0952-8180(00)00126-4.
       Full Text  Link to Item
    • Shah, A., G. S. Wagner, C. B. Granger, C. M. O’Connor, C. L. Green, K. M. Trollinger, R. M. Califf, and M. W. Krucoff. “Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment.” J Am Coll Cardiol 35, no. 3 (March 1, 2000): 666–72. https://doi.org/10.1016/s0735-1097(99)00601-4.
       Full Text  Link to Item
    • Morrison, D. A., G. Sethi, J. Sacks, F. Grover, S. Sedlis, R. Esposito, K. B. Ramanathan, et al. “A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs.” Control Clin Trials 20, no. 6 (December 1999): 601–19. https://doi.org/10.1016/s0197-2456(99)00033-1.
       Full Text  Link to Item
    • Drew, B. J., and M. W. Krucoff. “Multilead ST-segment monitoring in patients with acute coronary syndromes: a consensus statement for healthcare professionals. ST- Segment Monitoring Practice Guideline International Working Group.” Am J Crit Care 8, no. 6 (November 1999): 372–86.
       Link to Item
    • Corbalán, R., J. C. Prieto, E. Chavez, C. Nazzal, F. Cumsille, and M. Krucoff. “Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis.” Am Heart J 138, no. 3 Pt 1 (September 1999): 533–39. https://doi.org/10.1016/s0002-8703(99)70157-2.
       Full Text  Link to Item
    • Krucoff, M. W. “Mitchell W. Krucoff, MD. The MANTRA Study Project. Interview by Bonnie Horrigan.” Altern Ther Health Med 5, no. 3 (May 1999): 74–82.
       Link to Item
    • Blankenship, J. C., M. W. Krucoff, S. W. Werns, H. V. Anderson, C. Landau, H. J. White, C. L. Green, et al. “Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty.” Am J Cardiol 83, no. 5 (March 1, 1999): 675–80. https://doi.org/10.1016/s0002-9149(98)00969-2.
       Full Text  Link to Item
    • Drew, B. J., and M. W. Krucoff. “Multilead ST-segment monitoring in patients with acute coronary syndromes: A consensus statement for healthcare professionals.” American Journal of Critical Care 8, no. 6 (January 1, 1999): 372–88. https://doi.org/10.4037/ajcc1999.8.6.372.
       Full Text
    • Krucoff, M., S. Crater, C. Green, A. Maas, J. Seskevitch, K. Loeffler, and S. Raju. “Novel applications of ECG monitoring for the quantification of noetic phenomena.” Journal of Electrocardiology 32, no. SUPPL. (January 1, 1999): 22. https://doi.org/10.1016/S0022-0736(99)90029-8.
       Full Text
    • “Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial.” J Am Coll Cardiol 32, no. 7 (December 1998): 2003–10. https://doi.org/10.1016/s0735-1097(98)00474-4.
       Full Text  Link to Item
    • Conlon, P. J., M. W. Krucoff, S. Minda, D. Schumm, and S. J. Schwab. “Incidence and long-term significance of transient ST segment deviation in hemodialysis patients.” Clin Nephrol 49, no. 4 (April 1998): 236–39.
       Link to Item
    • Langer, A., M. W. Krucoff, P. Klootwijk, M. L. Simoons, C. B. Granger, A. Barr, R. M. Califf, and P. W. Armstrong. “Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.” J Am Coll Cardiol 31, no. 4 (March 15, 1998): 783–89. https://doi.org/10.1016/s0735-1097(97)00544-5.
       Full Text  Link to Item
    • Fisher, S. D., A. K. Loeffler, C. L. Green, N. M. Wildermann, J. E. Pope, and M. W. Krucoff. “Device implementation, validation, and application assessment of two continuous 12-lead ECG monitors during percutaneous transluminal coronary angioplasty: description of the validation method and implications for clinical trials.” J Electrocardiol 30 Suppl (1998): 149–54. https://doi.org/10.1016/s0022-0736(98)80064-2.
       Full Text  Link to Item
    • Krucoff, M. W., C. L. Green, A. Langer, P. Klootwijk, K. M. Trollinger, J. E. Pope, P. W. Armstrong, M. L. Simoons, E. J. Topol, and R. M. Califf. “Continuous 12-lead ST-segment recovery predicts outcome in acute myocardial infarction better than 'snapshot' angiograms of TIMI flow.” Journal of Electrocardiology 30, no. SUPPL. (January 1, 1998): 167. https://doi.org/10.1016/S0022-0736(98)80069-1.
       Full Text
    • Tomassoni, G., E. Pisanó, L. Gardner, M. W. Krucoff, and A. Natale. “QT prolongation and dispersion in myocardial ischemia and infarction.” J Electrocardiol 30 Suppl (1998): 187–90. https://doi.org/10.1016/s0022-0736(98)80073-3.
       Full Text  Link to Item
    • Topaz, O., M. McIvor, G. W. Stone, M. W. Krucoff, E. C. Perin, A. E. Foschi, J. Sutton, R. Nair, and E. deMarchena. “Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators.” Lasers Surg Med 22, no. 4 (1998): 228–39. https://doi.org/10.1002/(sici)1096-9101(1998)22:4<228::aid-lsm8>3.0.co;2-r.
       Full Text  Link to Item
    • Shah, A., G. S. Wagner, R. M. Califf, R. E. Boineau, C. L. Green, N. M. Wildermann, K. M. Trollinger, J. E. Pope, and M. W. Krucoff. “Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction.” J Am Coll Cardiol 30, no. 6 (November 15, 1997): 1478–83. https://doi.org/10.1016/s0735-1097(97)00331-8.
       Full Text  Link to Item
    • Shah, A., G. S. Wagner, C. L. Green, S. W. Crater, S. T. Sawchak, N. M. Wildermann, D. B. Mark, R. A. Waugh, and M. W. Krucoff. “Electrocardiographic differentiation of the ST-segment depression of acute myocardial injury due to the left circumflex artery occlusion from that of myocardial ischemia of nonocclusive etiologies.” Am J Cardiol 80, no. 4 (August 15, 1997): 512–13. https://doi.org/10.1016/s0002-9149(97)00406-2.
       Full Text  Link to Item
    • Seskevich, J., S. W. Crater, and M. W. Krucoff. “The Monitoring and Actualization of Noetic TRAining the MANTRA Study, a randomized controlled study of healing interventions.” Beginnings 17, no. 5 (May 1997): 9.
       Link to Item
    • Ohman, E. M., N. S. Kleiman, G. Gacioch, S. J. Worley, F. I. Navetta, J. D. Talley, H. V. Anderson, et al. “Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.” Circulation 95, no. 4 (February 18, 1997): 846–54. https://doi.org/10.1161/01.cir.95.4.846.
       Full Text  Link to Item
    • Conion, P. J., J. J. Walshe, S. K. Heinle, S. Minda, M. Krucoff, and S. J. Schwab. “Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients.” J Am Soc Nephrol 7, no. 12 (December 1996): 2658–63. https://doi.org/10.1681/ASN.V7122658.
       Full Text  Link to Item
    • Newby, K. H., E. Pisanó, M. W. Krucoff, C. Green, and A. Natale. “Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy.” Circulation 94, no. 10 (November 15, 1996): 2424–28. https://doi.org/10.1161/01.cir.94.10.2424.
       Full Text  Link to Item
    • Veldkamp, R. F., S. Sawchak, J. E. Pope, R. M. Califf, and M. W. Krucoff. “Performance of an automated real-time ST-segment analysis program to detect coronary occlusion and reperfusion.” J Electrocardiol 29, no. 4 (October 1996): 257–63. https://doi.org/10.1016/s0022-0736(96)80090-2.
       Full Text  Link to Item
    • Granger, C. B., J. M. Miller, E. G. Bovill, A. Gruber, R. P. Tracy, M. W. Krucoff, C. Green, et al. “Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.” Journal of Intravenous Nursing 19, no. 3 (May 1, 1996): 147–56.
    • O’Connor, C. M., R. B. Meese, S. McNulty, K. D. Lucas, R. J. Carney, R. M. LeBoeuf, W. Maddox, et al. “A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators.” Am J Cardiol 77, no. 10 (April 15, 1996): 791–97. https://doi.org/10.1016/s0002-9149(97)89171-0.
       Full Text  Link to Item
    • Lee, J. G., M. W. Krucoff, and S. R. Brazer. “Periprocedural myocardial ischemia in patients with severe symptomatic coronary artery disease undergoing endoscopy: prevalence and risk factors.” Am J Med 99, no. 3 (September 1995): 270–75. https://doi.org/10.1016/s0002-9343(99)80159-4.
       Full Text  Link to Item
    • Talley, J. D., and M. W. Krucoff. “Diagnosis and treatment of acute coronary ischemic syndromes: a update for 1995.” J Ark Med Soc 92, no. 3 (August 1995): 129–31.
       Link to Item
    • Langer, A., M. W. Krucoff, P. Klootwijk, R. Veldkamp, M. L. Simoons, C. Granger, R. M. Califf, and P. W. Armstrong. “Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.” J Am Coll Cardiol 25, no. 7 (June 1995): 1552–57. https://doi.org/10.1016/0735-1097(95)00110-p.
       Full Text  Link to Item
    • Granger, C. B., J. M. Miller, E. G. Bovill, A. Gruber, R. P. Tracy, M. W. Krucoff, C. Green, E. Berrios, R. A. Harrington, and E. M. Ohman. “Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.” Circulation 91, no. 7 (April 1, 1995): 1929–35. https://doi.org/10.1161/01.cir.91.7.1929.
       Full Text  Link to Item
    • Krucoff, M. W., K. A. Loeffler, W. K. Haisty, J. E. Pope, S. T. Sawchak, G. S. Wagner, and O. Pahlm. “Simultaneous ST-segment measurements using standard and monitoring-compatible torso limb lead placements at rest and during coronary occlusion.” Am J Cardiol 74, no. 10 (November 15, 1994): 997–1001. https://doi.org/10.1016/0002-9149(94)90847-8.
       Full Text  Link to Item
    • Anderson, S. T., O. Pahlm, R. H. Selvester, J. J. Bailey, A. S. Berson, S. S. Barold, P. Clemmensen, G. E. Dower, P. P. Elko, and P. Galen. “Panoramic display of the orderly sequenced 12-lead ECG.” J Electrocardiol 27, no. 4 (October 1994): 347–52. https://doi.org/10.1016/s0022-0736(05)80275-4.
       Full Text  Link to Item
    • Krucoff, M. W., R. F. Veldkamp, P. M. Kanani, S. Crater, S. R. Sawchak, N. M. Wildermann, J. R. Bengtson, J. E. Pope, M. H. Sketch, and H. R. Phillips. “The impact of autoperfusion on quantitative electrocardiographic parameters of ischemia severity, extent, and "burden" during salvage of elective coronary angioplasty.” J Invasive Cardiol 6, no. 7 (September 1994): 234–40.
       Link to Item
    • Ellis, S. G., A. M. Lincoff, B. S. George, D. J. Kereiakes, E. M. Ohman, M. W. Krucoff, R. M. Califf, and E. J. Topol. “Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.” Coron Artery Dis 5, no. 7 (July 1994): 611–15. https://doi.org/10.1097/00019501-199407000-00009.
       Full Text  Link to Item
    • Veldkamp, R. F., C. L. Green, M. L. Wilkins, J. E. Pope, S. T. Sawchak, J. A. Ryan, R. M. Califf, G. S. Wagner, and M. W. Krucoff. “Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group.” Am J Cardiol 73, no. 15 (June 1, 1994): 1069–74. https://doi.org/10.1016/0002-9149(94)90285-2.
       Full Text  Link to Item
    • Krucoff, M. W., C. L. Green, F. E. Harrell, M. L. Simoons, N. M. Wilderman, K. M. Trollinger, S. T. Sawchak, J. E. Pope, A. Shah, and C. B. Granger. “From signal/noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps: potential optimization of application-specific information content using left, right, and interval censoring.” J Electrocardiol 27 Suppl (1994): 233–37. https://doi.org/10.1016/s0022-0736(94)80097-9.
       Full Text  Link to Item
    • Shah, A., C. L. Green, K. M. Trollinger, N. M. Wilderman, J. E. Pope, R. M. Califf, G. S. Wagner, and M. W. Krucoff. “Reassessing the clinical significance of ST-segment depression that occurs concomitantly with the ST-segment elevation during acute myocardial infarction with the use of continuous ST-segment analysis.” J Electrocardiol 27 Suppl (1994): 256–59. https://doi.org/10.1016/s0022-0736(94)80101-0.
       Full Text  Link to Item
    • Krucoff, M. W., M. A. Croll, J. E. Pope, C. B. Granger, C. M. O’Connor, K. N. Sigmon, B. L. Wagner, J. A. Ryan, K. L. Lee, and D. J. Kereiakes. “Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study. Performance of a noninvasive method for real-time detection of failed myocardial reperfusion.” Circulation 88, no. 2 (August 1993): 437–46. https://doi.org/10.1161/01.cir.88.2.437.
       Full Text  Link to Item
    • Incorvati, R. L., S. G. Tauberg, M. J. Pecora, R. S. Macherey, M. W. Krucoff, S. B. Dianzumba, and B. C. Donohue. “Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty.” J Am Coll Cardiol 22, no. 1 (July 1993): 127–34. https://doi.org/10.1016/0735-1097(93)90826-m.
       Full Text  Link to Item
    • Tenaglia, A. N., J. P. Zidar, J. D. Jackman, D. F. Fortin, M. W. Krucoff, J. E. Tcheng, H. R. Phillips, and R. S. Stack. “Treatment of long coronary artery narrowings with long angioplasty balloon catheters.” Am J Cardiol 71, no. 15 (June 1, 1993): 1274–77. https://doi.org/10.1016/0002-9149(93)90539-o.
       Full Text  Link to Item
    • Natale, A., M. Wathen, K. Wolfe, R. Yee, G. M. Guiraudon, and G. J. Klein. “Comparative atrioventricular node properties after radiofrequency ablation and operative therapy of atrioventricular node reentry.” Pacing Clin Electrophysiol 16, no. 5 Pt 1 (May 1993): 971–77. https://doi.org/10.1111/j.1540-8159.1993.tb04570.x.
       Full Text  Link to Item
    • Krucoff, M. W., M. A. Croll, J. E. Pope, K. S. Pieper, P. M. Kanani, C. B. Granger, R. F. Veldkamp, B. L. Wagner, S. T. Sawchak, and R. M. Califf. “Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations.” Am J Cardiol 71, no. 2 (January 15, 1993): 145–51. https://doi.org/10.1016/0002-9149(93)90729-v.
       Full Text  Link to Item
    • Krucoff, M. W., C. L. Green, A. Langer, L. J. Klootwijk, K. M. Trollinger, S. T. Sawchak, N. M. Wilderman, R. F. Veldkamp, J. E. Pope, and M. L. Simoons. “Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.” J Electrocardiol 26 Suppl (1993): 249–55.
       Link to Item
    • Veldkamp, R. F., J. E. Pope, S. T. Sawchak, G. S. Wagner, R. M. Califf, and M. W. Krucoff. “ST-segment recovery as an endpoint in acute myocardial infarction trials. Past, present, and future.” J Electrocardiol 26 Suppl (1993): 256–61.
       Link to Item
    • Muhlestein, J. B., P. J. Quigley, E. M. Ohman, R. P. Bauman, M. H. Sketch, J. E. Tcheng, C. J. Davidson, R. H. Peter, V. S. Behar, and M. W. Krucoff. “Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans.” J Am Coll Cardiol 20, no. 3 (September 1992): 594–98. https://doi.org/10.1016/0735-1097(92)90013-d.
       Full Text  Link to Item
    • KRUCOFF, M. W., J. D. JACKMAN, S. W. CRATER, S. T. SAWCHAK, G. J. CURTIS, and H. R. PHILLIPS. ““Over The Shoulder” Guidewire Manipulation Through An Angulated Stenosis Adjacent To A Coronary Aneurysm During High Risk Percutaneous Transluminal Angioplasty.” Journal of Interventional Cardiology 5, no. 4 (January 1, 1992): 323–30. https://doi.org/10.1111/j.1540-8183.1992.tb00837.x.
       Full Text
    • Krucoff, M. W., M. Croll, J. Pope, J. Ryan, K. Pieper, S. Sawchak, B. Wagner, S. Crater, and R. Califf. “Unstable infarct artery. Quantification across angiographic subgroups using continuous digital 12-lead ST-segment recovery analysis.” J Electrocardiol 24 Suppl (1992): 15.
       Link to Item
    • Veldkamp, R. F., J. R. Bengtson, S. T. Sawchak, J. E. Pope, J. R. Mertens, D. W. Mortara, R. M. Califf, and M. W. Krucoff. “Evolution of an automated ST-segment analysis program for dynamic real-time, noninvasive detection of coronary occlusion and reperfusion.” J Electrocardiol 25 Suppl (1992): 182–87. https://doi.org/10.1016/0022-0736(92)90098-k.
       Full Text  Link to Item
    • Krucoff, M. W., M. B. Higginbotham, P. Van Trigt, S. T. Sawchak, R. H. Jones, T. C. Wall, H. R. Phillips, R. S. Stack, and J. G. Reeves. “From HIRMIT to the Cape May Lighthouse. Revascularization reconsidered in very high risk patients at the Duke Heart Center.” N C Med J 52, no. 12 (December 1991): 618–20.
       Link to Item
    • Davidson, C. J., K. H. Sheikh, K. B. Kisslo, H. R. Phillips, R. H. Peter, V. S. Behar, Y. H. Kong, M. Krucoff, E. M. Ohman, and J. E. Tcheng. “Intracoronary ultrasound evaluation of interventional technologies.” Am J Cardiol 68, no. 13 (November 15, 1991): 1305–9. https://doi.org/10.1016/0002-9149(91)90236-e.
       Full Text  Link to Item
    • Krucoff, M. W., J. E. Smith, J. D. Jackman, M. A. Croll, H. R. Phillips, and R. Stack. “"Hugging balloons" through a single 8-French guide: salvage angioplasty with lytic therapy in the infarct vessel of a 40-year-old man.” Cathet Cardiovasc Diagn 24, no. 1 (September 1991): 45–50. https://doi.org/10.1002/ccd.1810240111.
       Full Text  Link to Item
    • Stark, K. S., M. W. Krucoff, B. Schryver, and K. M. Kent. “Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block.” Am J Cardiol 67, no. 15 (June 1, 1991): 1219–22. https://doi.org/10.1016/0002-9149(91)90930-j.
       Full Text  Link to Item
    • Wagner, N. B., W. J. Elias, M. W. Krucoff, D. C. Sevilla, Y. R. Jackson, K. K. Kent, and G. S. Wagner. “Transient electrocardiographic changes of elective coronary angioplasty compared with evolutionary changes of subsequent acute myocardial infarction observed with continuous three-lead monitoring.” Am J Cardiol 66, no. 20 (December 15, 1990): 1509–12. https://doi.org/10.1016/0002-9149(90)90545-c.
       Full Text  Link to Item
    • Kent, K. M., M. W. Cleman, M. J. Cowley, M. B. Forman, C. C. Jaffe, M. Kaplan, S. B. King, M. W. Krucoff, T. Lassar, and B. McAuley. “Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol.” Am J Cardiol 66, no. 3 (August 1, 1990): 279–84. https://doi.org/10.1016/0002-9149(90)90836-p.
       Full Text  Link to Item
    • Krucoff, M. W., Y. R. Jackson, M. K. Kehoe, and K. M. Kent. “Quantitative and qualitative ST segment monitoring during and after percutaneous transluminal coronary angioplasty.” Circulation 81, no. 3 Suppl (March 1990): IV20–26.
       Link to Item
    • Krucoff, M. W., N. B. Wagner, J. E. Pope, D. M. Mortara, Y. R. Jackson, R. K. Bottner, G. S. Wagner, and K. M. Kent. “The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion.” Am J Cardiol 65, no. 3 (January 15, 1990): 143–48. https://doi.org/10.1016/0002-9149(90)90075-c.
       Full Text  Link to Item
    • Krucoff, M. W., M. A. Croll, J. E. Pope, C. B. Granger, K. S. Pieper, K. N. Sigmon, K. L. Lee, and R. M. Califf. “Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design.” J Electrocardiol 23 Suppl (1990): 6–10. https://doi.org/10.1016/0022-0736(90)90066-b.
       Full Text  Link to Item
    • Krucoff, M. W., Y. R. Jackson, M. K. Kehoe, and K. M. Kent. “Quantitative and qualitative ST segment monitoring during and after percutaneous transluminal coronary angioplasty.” Circulation 81, no. 3 SUPPL. (1990): IV20–26.
    • Stark, K. S., L. F. Satler, M. W. Krucoff, C. E. Rackley, and K. M. Kent. “Myocardial salvage after failed coronary angioplasty.” J Am Coll Cardiol 15, no. 1 (January 1990): 78–82. https://doi.org/10.1016/0735-1097(90)90179-s.
       Full Text  Link to Item
    • Schaer, G. L., M. W. Krucoff, C. Green, and M. S. Visner. “Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol.” Am Heart J 118, no. 4 (October 1989): 679–85. https://doi.org/10.1016/0002-8703(89)90579-6.
       Full Text  Link to Item
    • Krucoff, M. W., M. A. Croll, L. P. Pendley, D. L. Burdette, J. E. Pope, D. D. Hutchinson, J. S. Stone, R. A. Weber, and R. M. Califf. “Continuous computer-assisted electrocardiographic monitoring in patients with acute myocardial infarction: Early experience.” Computers in Cardiology, September 1, 1989, 197–200.
    • Wagner, N. B., D. C. Sevilla, M. W. Krucoff, K. S. Pieper, K. L. Lee, R. D. White, K. M. Kent, R. Renzi, R. H. Selvester, and G. S. Wagner. “Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the right and left circumflex coronary arteries.” Am J Cardiol 63, no. 17 (May 15, 1989): 1208–13. https://doi.org/10.1016/0002-9149(89)90180-x.
       Full Text  Link to Item
    • Mirvis, D. M., A. S. Berson, A. L. Goldberger, L. S. Green, J. J. Heger, T. Hinohara, J. Insel, M. W. Krucoff, A. Moncrief, and R. H. Selvester. “Instrumentation and practice standards for electrocardiographic monitoring in special care units. A report for health professionals by a Task Force of the Council on Clinical Cardiology, American Heart Association.” Circulation 79, no. 2 (February 1989): 464–71. https://doi.org/10.1161/01.cir.79.2.464.
       Full Text  Link to Item
    • Krucoff, M. W. “Electrocardiographic monitoring and coronary occlusion. Fingerprint pattern analysis in dimensions of space, time, and mind.” J Electrocardiol 22 Suppl (1989): 232–37.
       Link to Item
    • Wagner, N. B., D. C. Sevilla, M. W. Krucoff, K. L. Lee, K. S. Pieper, K. K. Kent, R. K. Bottner, R. H. Selvester, and G. S. Wagner. “Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary artery.” Am J Cardiol 62, no. 16 (November 15, 1988): 1038–42. https://doi.org/10.1016/0002-9149(88)90544-9.
       Full Text  Link to Item
    • Pilato, M. A., N. W. Fleming, N. M. Katz, J. J. O’Connell, M. W. Krucoff, R. E. Siegelman, and Y. D. Kim. “Treatment of non-cardiogenic pulmonary edema following cardiopulmonary bypass with veno-venous extracorporeal membrane oxygenation.” Anesthesiology 69, no. 4 (October 1988): 609–14. https://doi.org/10.1097/00000542-198810000-00028.
       Full Text  Link to Item
    • Krucoff, M. W., A. R. Parente, R. K. Bottner, R. H. Renzi, K. S. Stark, R. A. Shugoll, S. W. Ahmed, J. DeMichele, S. L. Stroming, and C. E. Green. “Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion.” Am J Cardiol 61, no. 15 (June 1, 1988): 1232–37. https://doi.org/10.1016/0002-9149(88)91161-7.
       Full Text  Link to Item
    • Krucoff, M. “Identification of high-risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multilead monitoring.” Am J Cardiol 61, no. 12 (April 21, 1988): 29F-35F. https://doi.org/10.1016/0002-9149(88)90053-7.
       Full Text  Link to Item
    • Kent, K. M., C. J. Ewels, and M. W. Krucoff. “Noninvasive assessment of patients following coronary artery angioplasty.” Cardiovasc Clin 19, no. 2 (1988): 199–208.
       Link to Item
    • Krucoff, M. W. “Poor performance of lead V5 in single- and dual-channel ST-segment monitoring during coronary occlusion.” J Electrocardiol 21 Suppl (1988): S30–34. https://doi.org/10.1016/0022-0736(88)90051-9.
       Full Text  Link to Item
    • Renzi, R. H., R. K. Bottner, S. L. Stroming, A. P. Parente, R. A. Shugoll, K. S. Stark, J. DiMichele, Y. R. Jackson, K. M. Kent, and M. W. Krucoff. “Quantitative ST-segment recovery following angiographically successful angioplasty: a useful warning of early complications.” J Electrocardiol 21 Suppl (1988): S27–29. https://doi.org/10.1016/0022-0736(88)90050-7.
       Full Text  Link to Item
    • Wagner, G. S., R. H. Selvester, N. B. Wagner, and M. W. Krucoff. “QRS changes during acute ischemia induced by balloon occlusion of the LAD artery.” J Electrocardiol 21 Suppl (1988): S18–19. https://doi.org/10.1016/0022-0736(88)90048-9.
       Full Text  Link to Item
    • Bottner, R. K., C. J. Morea, C. R. Green, R. H. Renzi, K. M. Kent, and M. W. Krucoff. “Quantitation of ischemia during total coronary occlusion with computer-assisted high resolution ST-segment monitoring: effect of collateral flow.” J Electrocardiol 20 Suppl (October 1987): 104–6.
       Link to Item
    • Krucoff, M. W., J. E. Pope, R. K. Bottner, R. H. Renzi, G. S. Wagner, and K. M. Kent. “Computer-assisted ST-segment monitoring: experience during and after brief coronary occlusion.” J Electrocardiol 20 Suppl (October 1987): 15–21.
       Link to Item
    • Krucoff, M., F. Chu, D. McCallum, and S. Perry. “New medical technologies in a cost containment environment: Implantable antitachyarrhythmia devices.” Pacing Clin Electrophysiol 10, no. 1 Pt 1 (January 1987): 2–20. https://doi.org/10.1111/j.1540-8159.1987.tb05920.x.
       Full Text  Link to Item
    • Miller, F. C., M. W. Krucoff, L. F. Satler, C. E. Green, R. D. Fletcher, A. A. Del Negro, D. L. Pearle, K. M. Kent, and C. E. Rackley. “Ventricular arrhythmias during reperfusion.” Am Heart J 112, no. 5 (November 1986): 928–32. https://doi.org/10.1016/0002-8703(86)90302-9.
       Full Text  Link to Item
    • Krucoff, M. W., C. E. Green, L. F. Satler, F. C. Miller, R. S. Pallas, K. M. Kent, A. A. Del Negro, D. L. Pearle, R. D. Fletcher, and C. E. Rackley. “Noninvasive detection of coronary artery patency using continuous ST-segment monitoring.” Am J Cardiol 57, no. 11 (April 15, 1986): 916–22. https://doi.org/10.1016/0002-9149(86)90730-7.
       Full Text  Link to Item

  • Book Sections

    • Kuijt, W. J., J. Williams, C. B. Granger, M. W. Krucoff, and M. T. Roe. “Current approaches to prevention and management of reperfusion injury.” In Management of Myocardial Reperfusion Injury, 9781849960199:215–38, 2012. https://doi.org/10.1007/978-1-84996-019-9_10.
       Full Text

  • Other Articles

    • Sarich, Troy C., Jonathan H. Seltzer, Scott D. Berkowitz, James Costin’, John T. Curnutte, C Michael Gibson, Maureane Hoffman, et al. “Novel oral anticoagulants and reversal agents: Considerations for clinical development.” Am Heart J, June 2015. https://doi.org/10.1016/j.ahj.2015.03.010.
       Full Text  Link to Item

  • Conference Papers

    • Baber, Usman, George Dangas, Samin K. Sharma, Dominick J. Angiolillo, Carlo Briguori, David J. Cohen, Timothy Collier, et al. “Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention for Acute Coronary Syndrome.” In Circulation, 140:E981–E981. LIPPINCOTT WILLIAMS & WILKINS, 2019.
       Link to Item
    • Reed, Shelby D., Angelyn O. Fairchild, F. R. Johnson, Juan M. Gonzalez, Robert J. Mentz, Mitchell W. Krucoff, and Sreekanth Vemulapalli. “Patients Accept Mortality Risk for Improvements in Physical Functioning in Secondary Mitral Regurgitation.” In Journal of Cardiac Failure, 25:S149–S149. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.430.
       Full Text
    • Crowley, Anna Lisa, Eric Yow, Dawn Rabineau, Casey Norris, Jennifer White, Melissa A. Daubert, Eric J. Velazquez, et al. “The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial.” In Jacc Cardiovasc Imaging, 11:1918–20, 2018. https://doi.org/10.1016/j.jcmg.2018.05.024.
       Full Text  Link to Item
    • Hall, Trygve Sørdahl, Jonas Hallén, Mitchell W. Krucoff, Matthew T. Roe, Danielle M. Brennan, Stefan Agewall, Dan Atar, and A Michael Lincoff. “Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.” In Am Heart J, 169:257-265.e1, 2015. https://doi.org/10.1016/j.ahj.2014.10.015.
       Full Text  Link to Item
    • Mauri, Laura, Dean J. Kereiakes, Robert W. Yeh, Priscilla Driscoll-Shempp, Donald E. Cutlip, Philippe G. Steg, Eugene Braunwald, et al. “Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study.” In Circulation, 130:2107–2107. LIPPINCOTT WILLIAMS & WILKINS, 2014.
       Link to Item
    • DeVore, Adam D., Eric Yow, Mitchell W. Krucoff, Linda K. Shaw, Karen Chiswell, Christopher M. O’Connor, E Magnus Ohman, and Eric J. Velazquez. “Outcomes After Percutaneous Coronary Intervention for Patients With Stable Coronary Disease and Left Ventricular Systolic Dysfunction.” In Circulation, Vol. 130. LIPPINCOTT WILLIAMS & WILKINS, 2014.
       Link to Item
    • Radhakrishnan, Vaishnavi, John C. Allen, Rebecca Fisher, Weng Kit Lye, Robert W. Harrison, and Mitchell W. Krucoff. “Generalizability of Quantitative Angiographic In-Segment Late Lumen Loss Imaging in Eastern and Western Populations: Can We Facilitate Global Drug Eluting Stent Evaluation?” In Circulation, Vol. 130. LIPPINCOTT WILLIAMS & WILKINS, 2014.
       Link to Item
    • Harskamp, Ralf F., Joost D. Haeck, Ecaterina Cristea, Jan G. Tijssen, Karel T. Koch, Mitchell W. Krucoff, and Robbert J. de Winter. “Anatomic and Physiologic Determinants of the Area-at-Risk Differentiate in Range of Infarct Size among Patients Undergoing Primary Percutaneous Coronary Intervention.” In Circulation, Vol. 126. LIPPINCOTT WILLIAMS & WILKINS, 2012.
       Link to Item
    • Sergie, Ziad, Samantha Sartori, Giora Weisz, Bernhard Witzenbichler, Timothy D. Henry, Annapoorna Kini, Thomas Stuckey, et al. “Lower Education Level is Associated with Non-Adherence to Dual Antiplatelet Therapy After PCI: 6-Month Results from PARIS.” In Circulation, Vol. 126. LIPPINCOTT WILLIAMS & WILKINS, 2012.
       Link to Item
    • Hermiller, James B., David R. Rutledge, Krishnankutty Sudhir, Gregg W. Stone, Patrick W. Serruys, Vivian W. Mao, Weiying Zhao, et al. “Stent Thrombosis after Implantation of XIENCE V Everolimus-Eluting Coronary Stent Systems in On-label and Off-label Populations: Pooled Two-Year Results from Seven XIENCE V Coronary Stent Trials.” In Journal of the American College of Cardiology, 58:B23–B23. ELSEVIER SCIENCE INC, 2011.
       Link to Item
    • Krucoff, Mitchell W., and Lea Lak. “Diastolic Heart Failure - Innovative Extra and Intra Ventricular Solutions.” In Journal of the American College of Cardiology, 58:B131–B131. ELSEVIER SCIENCE INC, 2011.
       Link to Item
    • Kuijt, Wichert J., Niels J. Verouden, Peter Damman, Joost D. Haeck, Karel T. Koch, Jan G. Tijssen, Mitchell W. Krucoff, and Robbert J. De Winter. “Post-Procedural ST-segment Deviation is an Independent Predictor of Long-Term Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-segment Elevation Myocardial Infarction.” In Journal of the American College of Cardiology, 58:B20–B20. ELSEVIER SCIENCE INC, 2011.
       Link to Item
    • Naidu, Srihari S., David R. Rutledge, James B. Hermiller, Vivian W. Mao, Weiying Zhao, Qing Zheng, Olivia Wilburn, and Mitchell W. Krucoff. “One-Year Clinical Outcomes and Multivariate Predictors Following XIENCE V (R) Everolimus Eluting Coronary Stent System Implantation in Real-World Clinical Settings.” In Journal of the American College of Cardiology, 58:B10–11. ELSEVIER SCIENCE INC, 2011.
       Link to Item
    • Rutledge, David R., James B. Hermiller, Jin Wang, and Mitchell W. Krucoff. “The Impact of XIENCE V (R) Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.” In Journal of the American College of Cardiology, 58:B52–53. ELSEVIER SCIENCE INC, 2011.
       Link to Item
    • Stone, Gregg W., David R. Rutledge, Krishnankutty Sudhir, James B. Hermiller, Patrick W. Serruys, Vivian W. Mao, Weiying Zhao, et al. “Stent Thrombosis and Dual Antiplatelet Interruption: Insights from the XIENCE V Everolimus-Eluting Coronary Stent System Trials.” In Journal of the American College of Cardiology, 58:B23–24. ELSEVIER SCIENCE INC, 2011.
       Link to Item
    • Gruberg, Luis, Allen Jeremias, David R. Rutledge, Vivian W. Mao, Weiying Zhao, Alena V. Pechonkina, Jin Wang, et al. “CLINICAL OUTCOMES IN REAL-WORLD PATIENTS RECEIVING THE XIENCE V® EVEROLIMUS-ELUTING STENT PRESENTING WITH CHRONIC KIDNEY DISEASE: ONE-YEAR RESULTS FROM THE XIENCE V USA STUDY.” In Journal of the American College of Cardiology, 57:E1896–E1896. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)61896-2.
       Full Text
    • Kuijt, Wichert J., Matthew T. Roe, Cindy L. Green, Karen S. Pieper, Susanna R. Stevens, Renato D. Lopes, Robert H. Christenson, et al. “PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION.” In Journal of the American College of Cardiology, 57:E1074–E1074. Elsevier BV, 2011. https://doi.org/10.1016/s0735-1097(11)61074-7.
       Full Text
    • Krucoff, Mitchell W., James Hermiller, Vivian Mao, Weiying Zhao, Jin Wang, Lalitha Jonnavithula, Stanley Fink, Krishnankutty Sudhir, and David Rutledge. “Predictors of 1-Year Clinical Outcomes in Real World Patients from XIENCE V (R) USA Study.” In Circulation, Vol. 122. LIPPINCOTT WILLIAMS & WILKINS, 2010.
       Link to Item
    • Sudhir, Krishnankutty, James B. Hermiller, Vivian W. Mao, Weiying Zhao, Joanne M. Ferguson, Jin Wang, Lalitha K. Jonnavithula, David R. Rutledge, and Mitchell W. Krucoff. “Low Clinical Event Rates in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V (R) Everolimus-Eluting Stents: One-Year Results from the XIENCE V USA Study.” In Circulation, Vol. 122. LIPPINCOTT WILLIAMS & WILKINS, 2010.
       Link to Item
    • Hermiller, James B., Mitchell W. Krucoff, Vivian Mao, Weiying Zhao, Alena V. Pechonkina, Jin Wang, Lalitha Jonnavithula, David R. Ruiledge, and Krishnankutty Sudhir. “Clinical Outcomes In Real-World Patients with Long Lesions Receiving the XIENCE Everolimus-Eluting Stein (ILLS): One Year Results From the XIENCIV USA Study.” In Journal of the American College of Cardiology, 56:B67–B67. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Hermiller, James B., Mitchell W. Krucoff, Vivian Mao, Weiying Zhao, Jin Wang, Olivia Wilburn, Stanley Fink, Krishnankutty Sudhir, and David R. Rutledge. “Predictors of Stent Thrombosis In Real World Patients From XIENCE V (R) USA Study.” In Journal of the American College of Cardiology, 56:B37–B37. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Krucoff, Mitchell W., David R. Rutledge, Vivian Mao, Weiying Zhao, Jin Wang, Olivia Wilburn, Krishnankutty Sudhir, and James B. Hermiller. “Consistent Efficacy and Safety of Everolimus-Eluting Stents In 5054 Patients From a Large Prospective Real World Study: One-Year Clinical Outcomes From the XIENCE V (R) USA Study.” In Journal of the American College of Cardiology, 56:B59–B59. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Kuiji, Wichert J., Joost D. E. Haeck, Peter Damman, Niels J. W. Verouden, Mitchell W. Krucoff, Jan G. P. Tijssen, Karel T. Koch, and Robbert J. De Winter. “Prediction of Infarct Size by Magnetic Resonance Imaging Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.” In Journal of the American College of Cardiology, 56:B19–B19. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Rutledge, David R., James B. Hermiller, Vivian Mao, Weiying Zhao, Alena V. Pechonkina, Jin Wang, Lalitha Jonnavithula, Charles A. Simonton, Mitchell W. Krucoff, and Krishnankutty Sudhir. “Low Clinical Event Rates in Real-World Patients Receiving the XIENCE V (R) Everolimus-Eluting Stent (EES) Via Direct Stenting: One-Year Results From the XIENCE V USA Study.” In Journal of the American College of Cardiology, 56:B60–B60. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Rutledge, David R., James B. Hermiller, Vivian W. Mao, Jin Wang, Qing Zheng, and Mitchell W. Krucoff. “The Impact of XIENCE NT Everolimus Eluting Stent on Health Status in On-Label and Off-Label Patients: One-Year Results from the XIENCE V USA Study.” In Journal of the American College of Cardiology, 56:B67–B67. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Rutledge, David R., James B. Hermiller, Vivian W. Mao, Jin Wang, Qing Zheng, and Mitchell W. Krucoff. “The Impact of XIENCE V (R) Everolimus Elating Stent on health Status in Patients with Varying Degrees of Renal Function: Results from the XIENCE V USA Study.” In Journal of the American College of Cardiology, 56:B70–B70. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Sudhir, Krishnankutty, James B. Hermiller, Vivian Mao, Weiying Zhao, Joanne Ferguson, Jin Wang, Lalitha Jonnavithula, David R. Rutledge, and Mitchell W. Krucoff. “Low Clinical Event Rates In Real-World Patients with Acute :Myocardial Infarction Receiving XIENCE Everolinms-Eluting Stents: One-Year Results From the XIENCE V USA Study.” In Journal of the American College of Cardiology, 56:B69–B69. ELSEVIER SCIENCE INC, 2010.
       Link to Item
    • Goldstein, James A., Simon R. Dixon, Philippe L. L’Allier, Jeffrey W. Moses, John L. Petersen, Donald E. Cutlip, Giora Weisz, et al. “Near-Infrared Spectroscopic Detection of Lipid-Core Coronary Plaques Remote From the Target Lesion in Patients Undergoing PCI.” In Journal of the American College of Cardiology, 53:A99–A99. ELSEVIER SCIENCE INC, 2009.
       Link to Item
    • Haeck, Joost D., Karel T. Koch, Luc Bilodeau, Rene J. Van der Schaaf, Jose P. Henriques, Jan Baan, Marije M. Vis, et al. “Randomized Comparison of Primary Percutaneous Coronary Intervention With Combined Proximal Embolic Protection and Thrombus Aspiration and Primary Percutaneous Coronary Intervention Alone in ST-segment Elevation Myocardial Infarction.” In Journal of the American College of Cardiology, 53:A28–A28. ELSEVIER SCIENCE INC, 2009.
       Link to Item
    • Haeck, Joost D., Niels J. Verouden, Wichert J. Kuijt, Rene J. Van der Schaaf, Jose P. Henriques, Marije M. Vis, Jan Baan, et al. “Immediate ST-Segment Resolution Is Associated With Left Ventricular Function and Infarct Size Measured by Cardiovascular Magnetic Resonance in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention.” In Journal of the American College of Cardiology, 53:A330–A330. ELSEVIER SCIENCE INC, 2009.
       Link to Item
    • Kuijt, Wichert J., Karel T. Koch, Joost D. Haeck, Niels J. Verouden, Jose P. Henriques, Jan Baan, Rene J. Van der Schaaf, et al. “Direct Presentation, Field-Referral, and Interhospital Transfer in a Network-Based System for Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Result in Similar 1-Year Mortality.” In Journal of the American College of Cardiology, 53:A57–A57. ELSEVIER SCIENCE INC, 2009.
       Link to Item
    • L’Allier, Philippe L., Jean-Claude Tardif, Simon R. Dixon, Jeffrey W. Moses, John L. Petersen, Giora Weisz, Donald E. Cutlip, et al. “Frequency of Lipid Core Plaque as Determined by Near-Infrared Spectroscopy at Target Lesion Sites in Patients Undergoing PCI.” In Journal of the American College of Cardiology, 53:A93–A93. ELSEVIER SCIENCE INC, 2009.
       Link to Item
    • Dixon, Simon R., Philippe L’Allier, Jeffrey W. Moses, John L. Petersen, Donald E. Cutlip, Cindy L. Grines, Giora Weisz, et al. “Near-infrared Spectroscopic Measurement of Lipid-Core Coronary Plaque Length: Implications for Complete Lesion Coverage in Patients Undergoing Stenting.” In American Journal of Cardiology, 102:19I-19I. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, 2008.
       Link to Item
    • Peterson, John L., Giora Weisz, Simon R. Dixon, Philippe L. L’Allier, Jeffrey W. Moses, Donald E. Cutlip, Sean P. Madden, et al. “Relationship of the Near Infrared Lipid Core Burden Index in Coronary Segments with Traditional Risk Factors in Patients Undergoing PCI.” In American Journal of Cardiology, 102:244I-244I. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, 2008.
       Link to Item
    • Ako, Junya, Ichizo Tsujino, Tomomi Koizumi, Katsuhisa Waseda, Yesuhiro Honda, Paul G. Yock, Dean J. Kereiakes, Mitchell W. Krucoff, and Peter J. Fitzgerald. “Overlapping drug-eluting stents: Intravascular ultrasound insights from cobalt chromium stent with antiproliferative for restenosis II (COSTAR II) trial.” In Journal of the American College of Cardiology, 51:B41–B41. ELSEVIER SCIENCE INC, 2008.
       Link to Item
    • Waxman, Sergio, Philippe L’Allier, James Goldstein, Mitchell W. Krucoff, Jean-Claude Tardif, Simon Dixon, John Peterson, et al. “Detection of lipid rich plaque by near-infrared spectroscopy (NIRS) in patients undergoing coronary intervention: Results in an unblinded cohort of the SPECTrospic assessment of coronary lipid (SPECTACL) study.” In American Journal of Cardiology, 100:231L-231L. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, 2007.
       Link to Item
    • Lemmert, Miguel E., Andrzej S. Kosinski, Mohamed Majidi, Harry J. Crijns, Hein J. Wellens, Mitchell W. Krucoff, and Anton P. Gorgels. “The role of RR-interval variability preceding ventricular fibrillation in ST elevation acute myocardial infarction.” In Circulation, 116:526–27. LIPPINCOTT WILLIAMS & WILKINS, 2007.
       Link to Item
    • Haugen, Scott J., Gregg W. Stone, Roxana Mehran, Alexandra J. Lansky, Mitchell W. Krucoff, John Webb, David A. Cox, Bruce R. Brodie, John D. Carroll, and JoAnn Lindenfeld. “Left ventricular end diastolic pressure is a predictor of suboptimal myocardial reperfusion in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction.” In Journal of the American College of Cardiology, 49:211A-212A. ELSEVIER SCIENCE INC, 2007.
       Link to Item
    • Majidi, Mohamed, Andrzej S. Kosinski, Same M. Al-Khatib, Miguel Lemmert, Ricardo G. Baeza, Suzanne W. Crater, Hein J. Wellens, Anton P. Gorgels, and Mitchell W. Krucoff. “Reperfusion "BURST" arrhythmias as a biomarker of myocellular damage despite TIMI 3 epicardial flow.” In Journal of the American College of Cardiology, 49:223A-224A. ELSEVIER SCIENCE INC, 2007.
       Link to Item
    • Majidi, Mohamed, Andrzej S. Kosinski, Sana M. Al-Khatib, Miguel Lemmert, Ricardo G. Baeza, Suzanne W. Crater, Hein W. Wellens, Anton P. Gorgels, and Mitchell W. Krucoff. “Ventricular arrhythmia "bursts" in the setting of acute anterior infarct artery recanalization: A re-definition of "reperfusion arrhythmias".” In Journal of the American College of Cardiology, 49:17A-18A. ELSEVIER SCIENCE INC, 2007.
       Link to Item
    • Drew, Barbara J., Claire E. Sommargren, Jessica K. Zegre, Daniel M. Schindler, Kent Benedict, and Mitchell W. Krucoff. “Effect of pre-hospital 12-lead ST-segment monitoring on time to treatment in acute coronary syndrome: the ST SMART study.” In Circulation, 114:352–352. LIPPINCOTT WILLIAMS & WILKINS, 2006.
       Link to Item
    • Mehran, Roxana, Dean J. Kereiakes, Peter Berger, Alexandra Lansky, William Wijns, Peter Fitzgerald, Wayne Batchelor, et al. “Overlapping paclitaxel elating stents: Early outcomes in the COSTAR II study.” In American Journal of Cardiology, 98:129M-129M. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC, 2006.
       Link to Item
    • Krucoff, Mitchell W., Cindy L. Green, Suzanne W. Crater, Ricardo Baeza, Galen Wagner, and Per Johanson. “1003-93 Outcomes prediction with continuous 12-lead ST-segment recovery in ST elevation myocardial infarction: Similarities or differences with thrombolytic versus direct stenting populations?” In Journal of the American College of Cardiology, 43:A247–A247. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91053-4.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.